Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1050.Time spend outdoors in summer,38611,0.00583767341480648,0.037379922549186,-0.0674269747815981,0.0791023216112111,0.875898766354982
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1060.Time spent outdoors in winter,33671,0.0216201931068611,0.0426770320292195,-0.062026789670409,0.105267175884131,0.612438684264767
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X1070.Time spent watching television (TV),40635,-0.0544127601485534,0.0372466531716431,-0.127416200364974,0.0185906800678672,0.144057072851927
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X1080.Time spent using computer,33681,0.0360784217604087,0.0390519445607224,-0.0404633895786073,0.112620233099425,0.355567269351515
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X1090.Time spent driving,29260,-0.0473533534022383,0.0427925932615923,-0.131226836194959,0.0365201293904826,0.268485412917035
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1160.Sleep duration,42796,0.00819888361198241,0.0342462560699055,-0.0589237782850324,0.0753215455089972,0.810789107694743
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,13962,0.00452702885672361,0.00731603809471595,-0.00981240580891965,0.0188664635223669,0.536070431610659
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,13962,-0.00836945462490699,0.00713303438103485,-0.0223502020117353,0.00561129276192132,0.240680643968967
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,13962,0.00624211540339553,0.00805552257994234,-0.00954670885329145,0.0220309396600825,0.438419887361351
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,13962,-0.00420954336084137,0.0082277388840296,-0.0203359115735394,0.0119168248518566,0.608919334048752
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,13962,0.00256727251384749,0.00834608612937975,-0.0137910562997368,0.0189256013274318,0.758389815667953
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,13962,-0.02700289001243,0.0179327438370552,-0.0621510679330582,0.00814528790819813,0.132144542671213
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,13962,-0.0101076353481341,0.0182458466705776,-0.0458694948224663,0.0256542241261981,0.579608870435015
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,13962,-0.000382224557396869,0.0128056022609351,-0.0254812049888297,0.024716755874036,0.976188521213697
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,13962,-0.00321283327257777,0.00946776520459988,-0.0217696530735935,0.015343986528438,0.734355393912775
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,13962,-0.00733809748277795,0.00640874380615554,-0.0198992353428428,0.0052230403772869,0.252223256615729
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#18.Location of pain during the past week_Upper back,13962,-0.002301977032949,0.00925883646521353,-0.0204492965047675,0.0158453424388695,0.803654627712449
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#19.Location of pain during the past week_Lower back,13962,-0.00819888184562711,0.00520556251889817,-0.0184017843826675,0.00200402069141331,0.115273764547405
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,13962,-0.00420887627630548,0.00669620642632773,-0.0173334408719078,0.00891568831929687,0.529656368968406
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,13962,-0.00663590994888147,0.00989351999640216,-0.0260272091418297,0.0127553892440668,0.502401767906231
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,13962,-0.00870191264725007,0.00928063839739468,-0.0268919639061436,0.00948813861164349,0.348444859712985
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,13962,0.000175547221126104,0.0123162385514728,-0.0239642803397606,0.0243153747820129,0.988628089358122
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,13962,-0.0124568614092821,0.0119307915583587,-0.0358412128636652,0.010927490045101,0.296460247340123
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#7.Location of pain during the past week_Left hip,13962,0.0024989869208725,0.00724852718903409,-0.0117081263696343,0.0167061002113793,0.730281593184676
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#8.Location of pain during the past week_Right hip,13962,0.00363868103990639,0.00686436466816012,-0.00981547370968745,0.0170928357895002,0.596063022773063
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,13962,0.00395263005459123,0.00858611483579619,-0.0128761550235693,0.0207814151327518,0.645271183443525
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120040.Fatigue severity over the past week,13977,-0.0774018720068775,0.0621691249211456,-0.199253356852323,0.044449612838568,0.213144893326995
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120041.Waking unrefreshed severity over the past week,13977,-0.0628214358761431,0.061707041302892,-0.183767236829811,0.0581243650775253,0.308667351153151
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120042.Cognitive symptoms severity over the past week,13975,-0.0376478927246362,0.0661618010410351,-0.167325022765065,0.0920292373157925,0.569346545722107
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120098.Mobility problems today,13983,-0.0058876823470475,0.0721754610844849,-0.147351586072638,0.135576221378543,0.934986191435361
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120099.Self-care problems today,13983,-0.0839039565635829,0.11311044223335,-0.30560042334095,0.137792510213784,0.458228331175105
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120100.Problems doing usual activities,13983,0.0630257555935183,0.0690007487299878,-0.0722157119172578,0.198267223104294,0.361044379242289
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120101.Pain or discomfort today,13983,-0.0307474329498914,0.0617652108359981,-0.151807246188448,0.090312380288665,0.618624739653783
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120102.Anxiety or depression today,13983,-0.0690420783461604,0.0754105621711822,-0.216846780201677,0.0787626235093567,0.359919204151135
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120103.Scale to indicate how health is today,13936,4.41451416328484e-05,0.00224815291571375,-0.00436223457316611,0.0044505248564318,0.984333881079583
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,13945,-0.12485609633711,0.0765661437379588,-0.274925738063509,0.0252135453892896,0.102977112054606
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",13921,-0.126288592738699,0.0789224836269223,-0.280976660647467,0.0283994751700685,0.109585835751361
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",13955,-0.0027631092777512,0.0622699153931702,-0.124812143448365,0.119285924892862,0.964607638006673
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,13958,-0.0823170277080442,0.0637295589964864,-0.207226963341158,0.0425929079250691,0.19649575390619
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,13962,-0.0161678001527379,0.082219316324213,-0.177317660148195,0.14498205984272,0.844110287006669
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120109.Feeling bad about self over the last two weeks,13925,0.0145002852576292,0.0822436533163197,-0.146697275242357,0.175697845757616,0.860053863865795
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120110.Trouble concentrating over the last two weeks,13963,-0.111520719898148,0.0828080527275207,-0.273824503244089,0.0507830634477922,0.17808663460239
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,13948,-0.288233999094044,0.124229328176112,-0.531723482319223,-0.044744515868864,0.020345689933991
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,13883,-0.11888699662857,0.166664873432839,-0.445550148556935,0.207776155299794,0.475653795446419
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",9695,0.0844851626418492,0.0836373743104102,-0.0794440910065549,0.248414416290253,0.312455159066575
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1269.Exposure to tobacco smoke at home,38633,-0.0135786669273962,0.0829699400636198,-0.176199749452091,0.149042415597299,0.870001500380266
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,36052,-0.0363061187860152,0.0507943049304513,-0.1358629564497,0.0632507188776693,0.474757345300852
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1289.Cooked vegetable intake,41548,-0.0594733198615053,0.036014110707538,-0.13006097684828,0.0111143371252692,0.0986666525340746
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1299.Salad  or  raw vegetable intake,40440,-0.008987532490449,0.0381341082703493,-0.0837303847003336,0.0657553197194357,0.813680437252003
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1309.Fresh fruit intake,41476,0.0162221819676531,0.0376323713680838,-0.0575372659137911,0.0899816298490973,0.666419798534593
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1319.Dried fruit intake,39192,0.0299267718383258,0.038741746570891,-0.0460070514406206,0.105860595117272,0.439841763853865
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X134.Number of self-reported cancers,43171,0.0138503969034949,0.0671147735963061,-0.117694559345265,0.145395353152255,0.836503795044769
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X135.Number of self-reported non-cancer illnesses,43172,-0.00180944625204732,0.0355409818290922,-0.071469770637068,0.0678508781329733,0.95939624245765
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X136.Number of operations, self-reported",43172,-0.0442554863995666,0.034908237464172,-0.112675631829344,0.0241646590302106,0.204888266592579
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X137.Number of treatments or medications taken,43172,-0.0051607481464289,0.0349386485575616,-0.0736404993192497,0.0633190030263919,0.882573224633383
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1438.Bread intake,41910,0.00120117419627355,0.00134707907217416,-0.0014391007851878,0.0038414491777349,0.372565327150965
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1458.Cereal intake,40956,-0.0222093427608035,0.0354994515496787,-0.0917882677981737,0.0473695822765667,0.531564454212441
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1488.Tea intake,41634,-9.67115674469836e-05,0.00128820286378991,-0.00262158918047521,0.00242816604558124,0.940155561766417
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1498.Coffee intake,39785,0.0448220298224787,0.0357026224129302,-0.0251551101068646,0.114799169751822,0.209331233402612
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1528.Water intake,39964,0.0224465792950573,0.0363041471692293,-0.0487095491566321,0.0936027077467467,0.536386117352377
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1568.Average weekly red wine intake,29344,0.0250091897590852,0.0424941075369873,-0.0582792610134099,0.10829764053158,0.556179040960589
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,29342,0.0241507323533886,0.0435480460533028,-0.0612034379110849,0.109504902617862,0.579188448150127
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1588.Average weekly beer plus cider intake,29424,-0.134706972184327,0.0484271761258487,-0.229624237390991,-0.0397897069776641,0.00541194236510251
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1598.Average weekly spirits intake,29305,-0.00634372330181701,0.0466149001394044,-0.0977089275750496,0.0850214809714156,0.891752737797233
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1608.Average weekly fortified wine intake,29400,-0.0594156364226447,0.0773915719953993,-0.211103117533627,0.092271844688338,0.442655276437512
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1737.Childhood sunburn occasions,32398,-0.0538171330303281,0.0420496592379619,-0.136234465136733,0.0286001990760773,0.200608095673175
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X1807.Father's age at death,31881,0.00041275825446957,0.00146283827461451,-0.00245440476377487,0.003279921272714,0.777820665023336
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X1845.Mother's age,16422,-9.43601697517792e-05,0.0034397071492078,-0.00683618618219907,0.00664746584269551,0.978115016830747
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X1873.Number of full brothers,42406,0.0149260425891498,0.0345715840093346,-0.0528342620691459,0.0826863472474456,0.665930339848052
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X1883.Number of full sisters,42409,0.0251002283442257,0.0345637559167948,-0.042644733252692,0.0928451899411435,0.467719670486232
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X20015.Sitting height,42834,0.00312909352674186,0.00169097151361451,-0.000185210639942577,0.0064433976934263,0.064252596090217
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20016.Fluid intelligence score,14019,0.0525669202920148,0.056680005554701,-0.058525890595199,0.163659731179229,0.353717643263601
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20018.Prospective memory result,14604,-0.0910199981285972,0.0738282671581857,-0.235723401758641,0.0536834055014468,0.217647458997331
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),13840,0.00519532751241003,0.00231887534500947,0.000650331836191469,0.00974032318862859,0.0250774497603149
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),13830,0.00428445803564635,0.002314347929306,-0.000251663905793401,0.0088205799770861,0.0641535894184755
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20023.Mean time to correctly identify matches,42652,0.000710372469007177,0.00135885066522478,-0.0019529748348334,0.00337371977284775,0.601133907372927
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#1.Illnesses of father_Heart disease,37586,-0.00166862686662833,0.00290336603591507,-0.00735922429702186,0.00402197056376521,0.565483109351526
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,36857,-0.00109642232673497,0.00637650500695984,-0.0135943721403763,0.0114015274869063,0.863479965431229
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,36794,0.000697681710844143,0.00861421983827591,-0.0161861891721766,0.0175815525938649,0.93544886451
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#12.Illnesses of father_Severe depression,36834,0.0013333202866097,0.00716907711317671,-0.0127180708552166,0.015384711428436,0.852459793545024
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,36860,0.0146568825512972,0.00514825146056635,0.00456630968858718,0.0247474554140073,0.00441628509963998
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#2.Illnesses of father_Stroke,37133,0.000194793528626254,0.00374467429577082,-0.00714476809108456,0.00753435514833707,0.958513979466784
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#3.Illnesses of father_Lung cancer,37043,0.00130272627377073,0.00473838321919975,-0.00798450483586078,0.0105899573834022,0.783371134585636
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,36865,-0.00951375709997751,0.00588229010211474,-0.0210430457001224,0.00201553150016737,0.10581001997221
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,37117,-0.000560681710649197,0.00432031366540757,-0.00902849649484803,0.00790713307354963,0.896742764637966
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#8.Illnesses of father_High blood pressure,37234,0.00140072001201296,0.00325921582486379,-0.00498734300472006,0.00778878302874598,0.667363921806573
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#9.Illnesses of father_Diabetes,36999,0.00475873794731704,0.00451588294814226,-0.00409239263104178,0.0136098685256759,0.291991467772021
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#1.Illnesses of mother_Heart disease,39367,-0.000587834389362181,0.0033225868090297,-0.00710010453506039,0.00592443575633603,0.859571588077645
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,39132,-0.00118645588728043,0.0047854541671066,-0.0105659460548094,0.00819303428024851,0.804190154383255
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,39005,0.00026899205446938,0.0105024802854278,-0.020315869304969,0.0208538534139078,0.979566753566891
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#12.Illnesses of mother_Severe depression,39063,0.000682796522454952,0.00534326992124107,-0.00979001252317754,0.0111556055680874,0.898318775491981
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#2.Illnesses of mother_Stroke,39267,0.00136700004990104,0.00378349125956728,-0.00604864281885082,0.0087826429186529,0.717872266855686
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,39089,0.000980829480325864,0.00671358061950087,-0.0121777885338958,0.0141394474945476,0.883846098293835
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,39054,0.000691069256311182,0.00601305634252454,-0.0110945211750369,0.0124766596876593,0.908502687890502
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,39086,-0.00451269093551792,0.004893966722204,-0.0141048657110378,0.00507948384000191,0.356485923660924
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,39138,-0.00256979041383273,0.005600222347422,-0.0135462262147799,0.0084066453871144,0.646327971165653
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,39449,0.00296270080818363,0.0028721137136613,-0.00266664207059252,0.00859204368695977,0.30229388428079
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#9.Illnesses of mother_Diabetes,39198,0.0029841493123275,0.00444093000744394,-0.00572007350226263,0.0116883721269176,0.501609971628773
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,33834,-0.0091955011029321,0.00465505054911218,-0.018319400179192,-7.16020266722326e-05,0.0482329789715573
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,33583,0.0064041654514673,0.0188111249470149,-0.0304656394446818,0.0432739703476164,0.733523084457286
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,33576,-0.00594760249747274,0.0186995621074061,-0.0425987442279887,0.0307035392330433,0.750440601461954
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,33677,0.00129324236355925,0.00553735582730388,-0.00955997505795635,0.0121464597850748,0.815336762648435
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,33602,0.0111862519226735,0.0109852230550464,-0.0103447852652174,0.0327172891105645,0.30854277393219
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#2.Illnesses of siblings_Stroke,33646,0.00535228522077186,0.00783090283042059,-0.0099962843268525,0.0207008547683962,0.494306698872836
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,33601,0.0130472711881701,0.00930556223037737,-0.00519163078336956,0.0312861731597097,0.160896477410863
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,33606,0.00160632135007958,0.00911768567067876,-0.0162643425644508,0.0194769852646099,0.860156395949376
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,33626,0.0013007129183027,0.00682810803674507,-0.0120823788337176,0.014683804670323,0.848923274500983
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,33648,-0.00952961407315308,0.00849566303710635,-0.0261811136258815,0.00712188547957538,0.261996580482509
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,33941,-0.00541597180635625,0.00347755499710156,-0.0122319796006753,0.00140003598796281,0.119382986864485
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,33761,-0.00648421528533312,0.00492966384825985,-0.0161463564279224,0.00317792585725619,0.188402468380089
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20127.Neuroticism score,34276,0.0317523195643601,0.0356885027389633,-0.0381971458040079,0.101701784932728,0.373629349853062
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,14019,0.0180156335393439,0.0575181898077641,-0.0947200184838737,0.130751285562562,0.754121017237932
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X20161.Pack years of smoking,13263,-0.00283878858226222,0.00245548907765526,-0.00765154717446653,0.00197397000994209,0.2476614922005
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,13263,-0.00279861346591903,0.00242191577516856,-0.0075455683852494,0.00194834145341134,0.247891398233084
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20191.Fluid intelligence score,10420,0.00856817256979961,0.0654994417562076,-0.119810733272367,0.136947078411967,0.895925841775563
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,10421,-0.0182553942006143,0.0661377798820925,-0.147885442769516,0.111374654368287,0.78253767869166
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20240.Maximum digits remembered correctly,9346,-0.049587865574424,0.0716042182486469,-0.189932133341772,0.0907564021929239,0.488623585247378
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X20255.Spirometry QC measure,31994,-0.0930835271477123,0.0459913360811552,-0.183226545866777,-0.00294050842864811,0.042985020181802
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X20261.avMSE,9603,-0.00368492685925945,0.00275410508513547,-0.00908297282612498,0.00171311910760607,0.180935946622056
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X20262.Myopia diagnosis,9603,0.0763239407722734,0.0851708277824209,-0.0906108816812715,0.243258763225818,0.370207044830867
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X20280.Glucose-lactate,23961,0.00164694612718587,0.00172838475486317,-0.00174068799234594,0.00503458024671769,0.340659653196164
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X20281.Spectrometer-corrected alanine,24007,-0.000666894305968444,0.00173243000333507,-0.00406245711250518,0.00272866850056829,0.700279849965308
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,13471,-0.00627774658912311,0.00912760933533649,-0.0241678608863826,0.0116123677081364,0.491605985329703
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,13469,-0.01364835031455,0.0179655848877098,-0.0488608966944613,0.0215641960653613,0.447450717153015
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),13469,0.0137510124788348,0.0223059305916786,-0.0299686114808553,0.0574706364385249,0.537592563915943
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),13469,-0.0025619328657846,0.00866440813200733,-0.019544172804519,0.0144203070729498,0.767475450201294
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),13469,0.00293337525845844,0.0148860873835683,-0.0262433560133353,0.0321101065302522,0.843787615559282
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,13477,-0.00382075917297759,0.0190892785795178,-0.0412357451888324,0.0335942268428772,0.841364651762904
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,13477,0.0120123424919183,0.012688287470988,-0.0128567009512183,0.0368813859350548,0.343794973931457
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,13477,0.00566354839268523,0.0140531462911098,-0.02188061833789,0.0332077151232605,0.686947795815338
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,13477,0.0127727947349964,0.0217623705992134,-0.0298814516394618,0.0554270411094546,0.557266532069848
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,13477,-0.00594204079617091,0.024768603442292,-0.0544885035430632,0.0426044219507213,0.810409779632673
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,13477,0.0112152108746404,0.0147611438567411,-0.0177166310845722,0.0401470528338529,0.447399849131648
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,13477,-0.0134464037443458,0.0245601257837063,-0.0615842502804102,0.0346914427917186,0.584051760349553
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,13477,0.0164289893688795,0.0181473870140018,-0.019139889178564,0.051997867916323,0.365318010144207
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),13479,0.0477688384827471,0.0254302915374744,-0.00207453293070267,0.0976122098961969,0.0603449427804197
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),13479,0.00952063601761942,0.0116619513562123,-0.0133367886405568,0.0323780606757956,0.414294716384983
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),13479,-0.00627169487773547,0.0174031963747725,-0.0403819597722896,0.0278385700168186,0.718571599523169
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,13480,0.0230709621279527,0.0295575265086059,-0.0348617898289149,0.0810037140848202,0.4350842174043
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20600.Liking for adding salt to foods,15242,-0.0759378055780873,0.055268904433931,-0.184264858268592,0.0323892471124174,0.169471293097204
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20601.Liking for aniseed,15242,-0.0226945834902395,0.0549842014790125,-0.130463618389104,0.085074451408625,0.67979754334815
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20602.Liking for apple juice,15242,0.0987116902230608,0.0550184226775748,-0.00912441822498573,0.206547798671107,0.0728079486055353
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20603.Liking for apples,15242,0.072906648377839,0.0557030480605881,-0.0362713258209136,0.182084622576592,0.190606668986479
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20604.Liking for asparagus,15242,0.00960577296824227,0.0558865440677524,-0.0999318534045525,0.119143399341037,0.863534243158845
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20605.Liking for aubergine,15242,0.0643479224780002,0.0554466419362479,-0.0443274957170457,0.173023340673046,0.245848127056519
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20606.Liking for avocados,15242,0.110226566363246,0.0556617851688512,0.00112946743229789,0.219323665294195,0.0476887503312769
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20607.Liking for bacon,15242,-0.0908343451575459,0.0559824879172028,-0.200560021475263,0.0188913311601715,0.104706504330583
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20608.Liking for baked or steamed fish,15242,0.0283080741709029,0.0567123355130818,-0.0828481034347374,0.139464251776543,0.61767954070048
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20609.Liking for bananas,15242,0.0309784574188419,0.0571924505359822,-0.0811187456316832,0.143075660469367,0.588065562624995
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20610.Liking for barbequed or grilled meat,15242,-0.125430017169011,0.055697889733346,-0.234597881046369,-0.0162621532916526,0.024338317344973
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20611.Liking for beef steak,15242,-0.148641102237457,0.0558160246975435,-0.258040510644643,-0.0392416938302722,0.00775164059332136
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20612.Liking for beetroot,15242,-0.0360887853817159,0.0562756365416714,-0.146389033003392,0.0742114622399602,0.521346453566166
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20613.Liking for bell pepper,15242,0.0440464110982193,0.0554350436589091,-0.0646062744732425,0.152699096669681,0.426882484169103
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20614.Liking for bicycling,15242,0.104025508800552,0.0550115492086331,-0.00379712764836869,0.211848145249473,0.0586465483988068
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20615.Liking for biscuits,15242,-0.0576144072986614,0.0550249517686031,-0.165463312765123,0.0502344981678007,0.295088691510771
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20616.Liking for bitter foods,15242,-0.00043325603866669,0.0553883770148769,-0.108994474987826,0.108127962910492,0.993758995679524
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20617.Liking for bitter or ale,15242,-0.0671439068444642,0.0558873293620045,-0.176683072393993,0.0423952587050646,0.229608740850803
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20618.Liking for black olives,15242,0.089066074054322,0.0552849795754107,-0.0192924859134829,0.197424634022127,0.107192685774676
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20619.Liking for black pepper,15242,0.0647035138663894,0.0556033272051898,-0.0442790074557827,0.173686035188562,0.24457900330111
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20620.Liking for blue cheese,15242,0.000194157513381618,0.0551974717820407,-0.107992887179418,0.108381202206181,0.997193487073406
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20621.Liking for bolognese sauce,15242,-0.0609327126271145,0.0551962031477431,-0.169117270796691,0.047251845542462,0.269641208646102
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20622.Liking for broad beans,15242,0.0304241445624836,0.0547616135628042,-0.0769086180206125,0.13775690714558,0.578510077860654
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20623.Liking for broccoli,15242,0.0656528934856225,0.0562592324618946,-0.0446152021396909,0.175920989110936,0.243240360208954
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20624.Liking for brown rice,15242,0.0986505664188728,0.0550974433809164,-0.00934042260772347,0.206641555445469,0.0733975351835796
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20625.Liking for brussel sprouts,15242,-0.0210221185635213,0.0552438609729837,-0.129300086070569,0.0872558489435268,0.703555029930169
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20626.Liking for burgers (meat),15242,-0.119184400301312,0.0548056836016882,-0.226603540160621,-0.0117652604420035,0.0296700333109393
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20627.Liking for burn of spicy foods,15242,-0.0491325255550844,0.0547120398488178,-0.156368123658767,0.0581030725485985,0.369188902990436
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20628.Liking for butter on bread,15242,0.0278490855035569,0.0558506024264328,-0.0816180952522513,0.137316266259365,0.618043493057624
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20629.Liking for butternut squash,15242,0.0794242291280686,0.0554498742990911,-0.0292575244981501,0.188105982754287,0.152061114788263
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20630.Liking for cabbage,15242,0.0341927810594699,0.0560947304168843,-0.0757528905576234,0.144138452676563,0.542166228582089
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20631.Liking for cake,15242,-0.055337210794433,0.0546812290279384,-0.162512419689192,0.0518379981003262,0.31155582942576
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20632.Liking for cake icing,15242,-0.0350349941143919,0.0551051017301667,-0.143040993505519,0.0729710052767349,0.524926160940599
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20633.Liking for capers,15242,-0.00366276736769747,0.054717128182898,-0.110908338606178,0.103582803870783,0.946630307515124
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20634.Liking for cauliflower,15242,0.0445491100461261,0.0560018637023259,-0.0652145428104327,0.154312762902685,0.426338985375103
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20635.Liking for cereal or granola bar,15242,-0.0152812148398059,0.0550703311294497,-0.123219063853527,0.0926566341739155,0.781411156367553
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20636.Liking for cheesecake,15242,0.0206173916950614,0.0548373694047187,-0.0868638523381871,0.12809863572831,0.706941919032422
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20637.Liking for cherries,15242,0.0748702351614291,0.0574898605582105,-0.0378098915326634,0.187550361855522,0.192826487892154
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20638.Liking for chicken,15242,-0.074202370938054,0.0584941737507146,-0.188850951489455,0.0404462096133467,0.204623530528965
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20639.Liking for chilli pepper,15242,0.0146217806189782,0.0549573988257762,-0.0930947210795431,0.1223382823175,0.790199195705047
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20640.Liking for chips or french fries,15242,-0.0960790473322063,0.0554873302465091,-0.204834214615364,0.0126761199509515,0.083374106040562
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20641.Liking for cigarette smoking,15242,0.00789889463598121,0.0892588216012456,-0.16704839570246,0.182846184974423,0.929484999366108
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20642.Liking for cod,15242,-0.0563952746441033,0.0573620718765241,-0.16882493552209,0.0560343862338839,0.325551360905368
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20643.Liking for coffee with sugar,15242,-0.00944654521783651,0.0598431804607167,-0.126739178920841,0.107846088485168,0.874573152864445
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20644.Liking for coffee without sugar,15242,0.0507901120481856,0.0558723345176537,-0.0587196636064158,0.160299887702787,0.363344114834685
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20645.Liking for coriander,15242,0.0179433385896487,0.0547335277036238,-0.0893343757094539,0.125221052888751,0.743044074274518
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20646.Liking for corn flakes,15242,0.00122714576408372,0.0549419445248383,-0.106459065504599,0.108913357032767,0.982180769584251
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20647.Liking for cream,15242,-0.0112198218551931,0.0550109762565392,-0.11904133531801,0.0966016916076237,0.838390564885289
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20648.Liking for croissant,15242,0.0236331365362088,0.0550080769737367,-0.0841826943323152,0.131448967404733,0.667470675716707
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20649.Liking for cucumber,15242,0.0644248888860834,0.0550234690854635,-0.0434211105214251,0.172270888293592,0.241672585201084
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20650.Liking for curry,15242,-0.0503192699170098,0.0558567594148223,-0.159798518370062,0.0591599785360419,0.367675591811874
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20651.Liking for dairy products,15242,0.0949856680109658,0.0561334848548595,-0.0150359623045588,0.20500729832649,0.090639913468902
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20652.Liking for dark chocolate,15242,-0.0246445414405119,0.0550907256917864,-0.132622363796413,0.0833332809153894,0.654632599240716
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20653.Liking for diet fizzy drinks,15242,-0.0911550655552897,0.0570822955130025,-0.203036364760775,0.0207262336501952,0.110307402890731
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20654.Liking for dried fruit,15242,0.0265101964047789,0.0553150295786927,-0.0819072615694589,0.134927654379017,0.631761649587074
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20655.Liking for eggs,15242,-0.00873640470586622,0.0563239801162037,-0.119131405733626,0.101658596321893,0.876736765594995
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20656.Liking for exercising alone,15242,0.0331071863001373,0.0550120093154164,-0.0747163519580788,0.140930724558353,0.547304633536537
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20657.Liking for exercising with others,15242,0.115865989345277,0.0547485924166235,0.00855874820869519,0.223173230481859,0.0343330940141981
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20658.Liking for extra virgin olive oil,15242,0.0568087141195396,0.05609260328132,-0.0531327883118476,0.166750216550927,0.311187766836451
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20659.Liking for fatty foods,15242,-0.0401990356331869,0.0548569806082453,-0.147718717625348,0.0673206463589738,0.463693483722835
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20660.Liking for fresh tomatoes,15242,0.1140875964023,0.0590824777018655,-0.00171405989335618,0.229889252697956,0.0535030007802244
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20661.Liking for fried chicken,15242,-0.138950451635496,0.0552653696819924,-0.247270576212201,-0.0306303270587908,0.0119391230749265
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20662.Liking for fried or battered fish,15242,-0.0994253617952333,0.0556992246906972,-0.208595842189,0.00974511859853325,0.074274687232596
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20663.Liking for fruit,15242,0.109162669861148,0.0618026651454952,-0.0119705538240231,0.230295893546318,0.0773638865568493
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20664.Liking for garlic,15242,0.0619071437610284,0.055718890831048,-0.0473018822678256,0.171116169789882,0.266559204107465
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20665.Liking for gherkins,15242,-0.0439999527830969,0.0551518228320416,-0.152097525533898,0.0640976199677046,0.425000813313077
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20666.Liking for globe artichoke,15242,0.10782915166634,0.0552363949238096,-0.000434182384326728,0.216092485717007,0.0509399490144278
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20667.Liking for goat's cheese,15242,0.0148487818466195,0.0550524542253657,-0.0930540284350973,0.122751592128336,0.787378855998495
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20668.Liking for going to a cafe,15242,0.024291593839549,0.0549932496654233,-0.0834951755046807,0.132078363183779,0.658698432275942
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20669.Liking for going to the gym,15242,0.0978291547192684,0.0537079262555957,-0.00743838074169918,0.203096690180236,0.0685500357363193
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20670.Liking for going to the pub,15242,-0.0318183086134179,0.0546684403172489,-0.138968451635226,0.0753318344083899,0.560559576184541
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20671.Liking for grapefruit,15242,0.026437446617577,0.0540572103860432,-0.0795146857390677,0.132389578974222,0.624803290125946
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20672.Liking for green olives,15242,0.100910866262695,0.0554281300902499,-0.00772826871419501,0.209550001239585,0.0686916686918917
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20673.Liking for haddock,15242,-0.0838440436741949,0.0571560124438138,-0.19586982806407,0.0281817407156802,0.142414931645255
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20674.Liking for ham,15242,-0.143755213117099,0.0558449384544087,-0.25321129248774,-0.0342991337464579,0.0100570154850604
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20675.Liking for hard cheese,15242,0.0814928726384286,0.0564303346019326,-0.0291105831813593,0.192096328458216,0.148722330569008
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20676.Liking for herring,15242,-0.00626761584019812,0.0553296995059499,-0.11471382687186,0.102178595191464,0.909811965761141
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20677.Liking for honey,15242,0.0294894067958434,0.0546595760531355,-0.0776433622683022,0.136622175859989,0.589542652856033
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20678.Liking for horseradish or wasabi,15242,-0.0205810260684771,0.0552163456518601,-0.128805063546123,0.0876430114091687,0.709351394361876
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20679.Liking for ice cream,15242,-0.0150672215765785,0.0553270774019289,-0.123508293284359,0.0933738501312021,0.785372005036107
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20680.Liking for jam,15242,-0.0310173981514095,0.0547848984591052,-0.138395799131256,0.0763610028284367,0.571288651567932
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20681.Liking for kiwi fruit,15242,0.0467653373370575,0.0552259050907682,-0.0614774366408482,0.155008111314963,0.397119510504033
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20682.Liking for lager,15242,0.0489067878692444,0.0548674904521742,-0.058633493417017,0.156447069155506,0.372749168302306
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20683.Liking for lamb,15242,-0.0508785556001745,0.0560624791566862,-0.16076101474728,0.0590039035469305,0.364139322328681
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20684.Liking for lemons,15242,0.0636247970023562,0.0555488108159222,-0.0452508721968513,0.172500466201564,0.252067553497018
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20685.Liking for lentils or beans,15242,0.0666756992479197,0.0552436743890439,-0.0416019025546064,0.174953301050446,0.227474715422169
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20686.Liking for liver,15242,-0.138830274328914,0.0556043499977206,-0.247814800324446,-0.0298457483333815,0.0125441435332715
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20687.Liking for mackerel,15242,0.0383859499277472,0.0556913409348325,-0.0707690783045245,0.147540978160019,0.490668633551901
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20688.Liking for marzipan,15242,0.0933957983506788,0.0550044842141656,-0.0144129907090857,0.201204587410443,0.0895344357512355
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20689.Liking for mayonnaise,15242,0.0256938878085821,0.0555466721924036,-0.083177589688529,0.134565365305693,0.64368357069202
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20690.Liking for melon,15242,0.117883689184688,0.0567337739935619,0.00668549215730659,0.229081886212069,0.0377408467649906
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20691.Liking for milk chocolate,15242,-0.0570958727162958,0.0555319725797068,-0.165938538972521,0.0517467935399295,0.303889896412874
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20692.Liking for mushrooms,15242,0.0190233054348295,0.056631211329547,-0.0919738687710826,0.130020479640742,0.736939168842824
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20694.Liking for orange juice,15242,0.0522370417468161,0.0550804549980364,-0.0557206500493354,0.160194733542968,0.342952575662256
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20695.Liking for oranges,15242,0.0258119535106463,0.0555462547825041,-0.0830587058630619,0.134682612884354,0.64215799889818
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20696.Liking for pasta,15242,0.013416438546018,0.0557468288438001,-0.0958473459878302,0.122680223079866,0.809816229979986
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20697.Liking for pears,15242,0.120275289023703,0.0559082853853003,0.0106950496685147,0.229855528378892,0.0314685073452996
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20698.Liking for pizza,15242,0.0698123878799331,0.0549733131554218,-0.0379353059046936,0.17756008166456,0.204128150441555
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20699.Liking for plain yogurt,15242,0.0563828287649272,0.0545401612566335,-0.0505158872980746,0.163281544827929,0.301252870786556
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20700.Liking for plums,15242,0.0984062348179223,0.0559887224630809,-0.0113316612097162,0.208144130845561,0.0788343082354322
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20701.Liking for pollock,15242,-0.0862709970251881,0.054719029766392,-0.193520295367317,0.0209783013169403,0.114904276157477
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20702.Liking for pork chop,15242,-0.122146313525056,0.0551766281592488,-0.230292504717184,-0.0140001223329285,0.0268619331734046
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20703.Liking for porridge,15242,-0.0172078763381453,0.056194341524195,-0.127348785725567,0.0929330330492769,0.759440723663727
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20704.Liking for potato crisps,15242,-0.0578028529652142,0.056012569177127,-0.167587488552383,0.0519817826219547,0.302106233966844
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20705.Liking for potatoes,15242,-0.0170119780611383,0.0557999325228511,-0.126379845805926,0.0923558896836499,0.760465885566453
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20706.Liking for prawns,15242,0.0200582265097511,0.0559805699096059,-0.0896636905130765,0.129780143532579,0.720118597284563
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20707.Liking for raw carrots,15242,0.0619804480059703,0.0553093283395656,-0.0464258355395783,0.170386731551519,0.2624695753301
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20708.Liking for red meat,15242,-0.19519859516747,0.0558405961990098,-0.304646163717529,-0.0857510266174104,0.000474273602524371
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20709.Liking for red wine,15242,0.0189439895261908,0.0550226939027246,-0.0889004905231493,0.126788469575531,0.730629868994037
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,15242,-0.111650304882912,0.0567084731648448,-0.222798912286008,-0.000501697479816154,0.0489887845077067
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20711.Liking for roast chicken,15242,-0.0518122144093162,0.0585469017504345,-0.166564141840168,0.0629397130215353,0.376187136089705
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20712.Liking for salad dressing,15242,0.13914249416341,0.0557123955014253,0.0299461989806169,0.248338789346204,0.0125172244955685
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20713.Liking for salad leaves,15242,0.162662252321763,0.0564441842671789,0.0520316511580922,0.273292853485433,0.00395932343800912
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20714.Liking for salami,15242,-0.0806386392954828,0.0555936906248306,-0.189602272920151,0.0283249943291852,0.146939792898633
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20715.Liking for salmon,15242,0.0626391430029154,0.0587959212831265,-0.0526008627120126,0.177879148717843,0.286727487635455
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20716.Liking for salty foods,15242,-0.0584786799028754,0.0554508556258243,-0.167162356929491,0.0502049971237403,0.291623332865611
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20717.Liking for salty pretzels,15242,-0.106893027028487,0.0550006114817662,-0.214694225532749,0.000908171475774378,0.0519756370700975
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20718.Liking for sardines,15242,-0.00295710451042654,0.0554069366862558,-0.111554700415488,0.105640491394635,0.957437286184199
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20719.Liking for sausages (meat),15242,-0.133072774964713,0.0554164297629448,-0.241688977300085,-0.0244565726293414,0.0163478057514902
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20720.Liking for savoury biscuits,15242,0.0161967631615598,0.0557395735070683,-0.093052800912294,0.125446327235414,0.771377095227057
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20721.Liking for shellfish (other than prawns),15242,-0.0979410084642198,0.0549998916985573,-0.205740796193392,0.00985877926495246,0.0749733870601577
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20722.Liking for skimmed milk,15242,0.0373160829178086,0.0548635769941389,-0.0702165279907038,0.144848693826321,0.496412667395064
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20723.Liking for smoked fish,15242,-0.0728582710935593,0.0555664502198256,-0.181768513524418,0.036051971337299,0.18981277111905
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20724.Liking for soft cheese,15242,0.0166952687184602,0.055592848543111,-0.0922667144260373,0.125657251862958,0.763942333431483
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20725.Liking for soy sauce,15242,-0.0257593446690632,0.0551676269818215,-0.133887893553433,0.0823692042153069,0.640557622868019
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20726.Liking for soya milk,15242,-0.0036583258428691,0.0551805265438548,-0.111812157868825,0.104495506183086,0.947141918204246
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20727.Liking for spicy foods,15242,0.0036749212464427,0.055137425635883,-0.104394432999888,0.111744275492773,0.94686104467782
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20728.Liking for spinach,15242,0.00279137476075716,0.0559094112022584,-0.106791071195669,0.112373820717184,0.960181421847851
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20729.Liking for spirits,15242,-0.0805833351941271,0.055214726628849,-0.188804199386671,0.027637528998417,0.144460923947618
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20730.Liking for strawberries,15242,-0.00634944790497509,0.0599257444060594,-0.123803906940851,0.111105011130901,0.915619245082394
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20731.Liking for sweet coffee house drinks,15242,-0.147498448188278,0.0567028218511454,-0.258635979016523,-0.0363609173600326,0.00929735047984759
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20732.Liking for sweet foods,15242,-0.128902017925775,0.0551304445434763,-0.236957689230989,-0.0208463466205616,0.0193935083719636
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20733.Liking for taking the stairs,15242,0.0147003712579066,0.0563122266411363,-0.0956715929587206,0.125072335474534,0.794056598257731
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20734.Liking for tea with sugar,15242,-0.00181833203837478,0.0663910215950664,-0.131944734364705,0.128308070287955,0.978150451308528
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20735.Liking for tea without sugar,15242,-0.00953659960312516,0.0571618645675993,-0.12157385415562,0.10250065494937,0.867502096032354
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20736.Liking for tomato ketchup,15242,-0.0759907452815995,0.0545832374658236,-0.182973890714614,0.0309924001514148,0.163882395094975
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20737.Liking for tinned tuna,15242,0.0172269230598081,0.0559911288100651,-0.0925156894079195,0.126969535527536,0.758335859522674
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20738.Liking for turnip (white),15242,-0.0265534844416083,0.0550416179586523,-0.134435055640567,0.0813280867573502,0.62951059181196
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20739.Liking for vegetables,15242,0.0920755692947427,0.0607581489341931,-0.0270104026162757,0.211161541205761,0.129680782246877
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20740.Liking for vinegar,15242,-0.00475125472859788,0.0557767783861229,-0.114073740365399,0.104571230908203,0.932116720746339
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20741.Liking for watching television,15242,-0.100938328849297,0.0558819878120553,-0.210467024960925,0.00859036726233149,0.0708948861047362
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20742.Liking for whisky,15242,-0.0271065373623347,0.0563590846237283,-0.137570343224842,0.0833572685001729,0.630550933858209
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20743.Liking for white bread,15242,-0.0327958455759434,0.0545334488504013,-0.13968140532273,0.0740897141708433,0.547589523025768
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20744.Liking for white rice,15242,-0.0953306356674918,0.0550439717460973,-0.203216820289843,0.0125555489548589,0.0833116926694931
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20745.Liking for white wine,15242,-0.0149224827925794,0.0554505589177556,-0.12360557827138,0.0937606126862216,0.787846145478057
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,15242,0.0521313748422328,0.0553763701176607,-0.056406310588382,0.160669060272848,0.346514300625404
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20747.Liking for whole milk,15242,-0.0696470688268593,0.0541449025425428,-0.175771077810243,0.0364769401565245,0.198354853074475
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20748.Liking for wholemeal bread,15242,0.108086997812148,0.0575843631810677,-0.00477835402274515,0.22095234964704,0.06053447567925
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20749.Liking for working up a sweat,15242,0.069982895585843,0.054926725138769,-0.0376734856861443,0.17763927685783,0.202642562683008
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X21001.Body mass index (BMI),42971,-0.00403507938978687,0.00557010034326315,-0.0149524760625826,0.00688231728300891,0.468813269764275
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X21002.Weight,43002,0.00442067902383475,0.00314489371189766,-0.00174331265148466,0.0105846706991542,0.159829717885389
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X21021.Pulse wave Arterial Stiffness index,14501,-0.000199954140246505,0.00229288167422504,-0.00469400222172758,0.00429409394123457,0.930508593828444
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,14598,-0.0423394649546954,0.0579405097303159,-0.155902864026115,0.0712239341167239,0.464949543250812
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,14612,-0.0390783053802456,0.0600365904434715,-0.15675002264945,0.0785934118889586,0.515116034077707
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,14614,-0.0061702072940262,0.0590030921624555,-0.121816267932439,0.109475853344387,0.916715042126072
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21040.Satisfaction with bowel habits,14544,-0.0313309155788381,0.0543420899409746,-0.137841411863148,0.0751795807054722,0.564252624255394
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,14524,0.00318809741804636,0.0580159001094372,-0.110523066796451,0.116899261632543,0.956177356060189
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21042.Greatest number of times bowels opened per day,14539,0.0181632526152085,0.0595319634092652,-0.0985193956669512,0.134845900897368,0.760293716078064
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21043.Least number of times bowels opened per week,14429,-0.016879561910884,0.0583082451420152,-0.131163722389234,0.0974045985674658,0.772211801898392
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21044.Average number of times bowels opened per day,14493,-0.00395892273594176,0.0652963313843647,-0.131939732249297,0.124021886777413,0.95165464300039
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,14619,-0.00442467117919397,0.0588006646344228,-0.119673973862663,0.110824631504275,0.94001790023633
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,14609,0.0210856646472816,0.0599649776082487,-0.0964456914648859,0.138617020759449,0.72511859401492
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,8233,0.0582538024705173,0.0923030599895997,-0.122660195109098,0.239167800050133,0.527983192139703
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,14616,0.00770984602944791,0.0644092479537218,-0.118532279959847,0.133951972018743,0.904721720960207
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,14612,0.055713388241129,0.0899001358620702,-0.120490878048529,0.231917654530787,0.535448332273344
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,14612,0.00203704735880473,0.0698960858290225,-0.134959280866079,0.139033375583689,0.976750189728725
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,14611,0.00541910402805135,0.175271950097286,-0.338113918162629,0.348952126218731,0.97533514885773
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,14619,0.00818913796408434,0.0679702598597663,-0.125032571361058,0.141410847289226,0.904103634716846
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,14615,0.0572970624884731,0.0677385244551284,-0.0754704454435785,0.190064570420525,0.397646736105637
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,14272,0.000750779860091065,0.0618681712191211,-0.120510835729386,0.122012395449568,0.990317954462477
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,14612,-0.0876355375744362,0.0605803639730696,-0.206373050961652,0.0311019758127801,0.148030536781441
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,14615,0.217761008283565,0.0905845869589733,0.0402152178439777,0.395306798723153,0.0162312799866526
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,14619,0.0548958271543795,0.0603911405997008,-0.0634708084210341,0.173262462729793,0.363362676054259
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,14617,-0.0736678913970402,0.0596362786934191,-0.190554997636142,0.0432192148420613,0.216743761928127
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X21100.Water hardness (USGS classification),42741,-0.0404113282901772,0.0351491753506049,-0.109303711977363,0.0284810553970084,0.250270122572439
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2139.Age first had sexual intercourse,37261,0.0026099424443762,0.0014459083017006,-0.000224037826956989,0.00544392271570938,0.0710743174853261
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2149.Lifetime number of sexual partners,34577,0.0054006465440646,0.0392947325970061,-0.0716170293460673,0.0824183224341966,0.890684248735856
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22032.IPAQ activity group,34548,-0.016523268098343,0.0386584005309069,-0.0922937331389207,0.0592471969422346,0.669078094252357
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22033.Summed days activity,35458,-0.000313838582721499,0.0013945184660817,-0.00304709477624162,0.00241941761079863,0.821940446464471
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22034.Summed minutes activity,34548,-0.00178727290858038,0.0014055148129372,-0.00454208194193729,0.000967536124776529,0.203518713192513
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22037.MET minutes per week for walking,33063,-0.00284722985978792,0.00143829233440394,-0.00566628283521965,-2.81768843561864e-05,0.0477578432859503
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22038.MET minutes per week for moderate activity,34548,-0.000590208701965806,0.00140743176535978,-0.00334877496207098,0.00216835755813937,0.674961830747214
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22039.MET minutes per week for vigorous activity,34548,0.0121797450386707,0.0386733527536871,-0.063620026358556,0.0879795164358974,0.752809911696987
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22040.Summed MET minutes per week for all activity,33063,-0.000768730793875404,0.0014421220790093,-0.00359529006873363,0.00205782848098282,0.593998896135303
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X2217.Age started wearing glasses or contact lenses,36687,-0.000880718726107429,0.00140502165178521,-0.00363456116360644,0.00187312371139158,0.530770377020518
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X22501.Year ended full time education,10217,0.00467761898059726,0.00652638832342509,-0.00811410213331592,0.0174693400945104,0.473560835007576
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X22506.Tobacco smoking,10153,0.0995521863894684,0.143190373716857,-0.181100946095571,0.380205318874507,0.486918608908407
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,40348,0.14642559665974,0.0869803573121413,-0.0240559036720568,0.316907096991537,0.0922990542834735
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23098.Weight,42269,0.00484942986558624,0.00317411204407106,-0.00137182974079303,0.0110706894719655,0.126568006278873
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23099.Body fat percentage,42240,-0.00546735665106069,0.00304648563601681,-0.0114384684976536,0.000503755195532248,0.0727176148754312
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23100.Whole body fat mass,42197,-0.00245785872574617,0.00294412857869877,-0.00822835073999577,0.00331263328850343,0.403815890666621
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23101.Whole body fat-free mass,42264,0.00589019680579158,0.0026505848899276,0.00069505042153349,0.0110853431900497,0.0262733578703454
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23102.Whole body water mass,42269,0.00598888220363651,0.00265393291233949,0.000787173695451109,0.0111905907118219,0.0240377623767528
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23104.Body mass index (BMI),42269,-0.00365217985497417,0.00559927589006249,-0.0146267605994967,0.00732240088954831,0.514237449537186
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23105.Basal metabolic rate,42267,0.00618520969337611,0.00283559275322364,0.000627447897057769,0.0117429714896944,0.0291685206635359
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23106.Impedance of whole body,42263,-0.00407702040788523,0.00217033340728054,-0.00833087388615508,0.00017683307038462,0.060316585054593
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23107.Impedance of leg (right),42266,-0.00131900086679209,0.00177621874125156,-0.00480038959964514,0.00216238786606097,0.457734553110548
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23108.Impedance of leg (left),42265,-0.00179211542656803,0.00175876540051984,-0.00523929561158692,0.00165506475845086,0.308226756332213
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23109.Impedance of arm (right),42258,-0.00333709093830346,0.00216547389878565,-0.00758141977992333,0.000907237903316403,0.123313525196508
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23110.Impedance of arm (left),42264,-0.00336055215379968,0.00216536885610729,-0.00760467511176996,0.000883570804170601,0.120680798548227
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23111.Leg fat percentage (right),42265,-0.00321506552494368,0.0036895990346334,-0.0104466796328251,0.00401654858293777,0.383548292698432
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23112.Leg fat mass (right),42264,-0.00242985623423491,0.00392010097696271,-0.0101132541490818,0.005253541680612,0.53536297266523
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23113.Leg fat-free mass (right),42263,0.00371694939729328,0.00277732459669056,-0.00172660681222023,0.00916050560680678,0.180799306836449
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23114.Leg predicted mass (right),42262,0.00365588716827584,0.00279127504099715,-0.00181501191207856,0.00912678624863025,0.190285764597469
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23115.Leg fat percentage (left),42259,-0.00525420370814619,0.00383383233284575,-0.0127685150805239,0.00226010766423147,0.170543324537616
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23116.Leg fat mass (left),42259,-0.0033727806997452,0.00407932901417699,-0.0113682655675321,0.00462270416804169,0.408356285128059
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23117.Leg fat-free mass (left),42256,0.00464810302265954,0.00289570047839065,-0.00102746991498614,0.0103236759603052,0.108463000259137
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23118.Leg predicted mass (left),42255,0.00449253022340098,0.00291058970320268,-0.00121222559487626,0.0101972860416782,0.122714081839668
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23119.Arm fat percentage (right),42255,-0.00482373403922248,0.00338746977443383,-0.0114631747971128,0.00181570671866782,0.154455817378533
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23120.Arm fat mass (right),42252,-0.000642572924800013,0.00335573654893648,-0.00721981656071551,0.00593467071111548,0.848146619090816
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23121.Arm fat-free mass (right),42252,0.00503892710055527,0.00267140306418342,-0.000197022905244229,0.0102748771063548,0.0592684770751062
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23122.Arm predicted mass (right),42251,0.0057207743853463,0.00267427012146621,0.000479204947272536,0.0109623438234201,0.0324259244211809
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23123.Arm fat percentage (left),42247,-0.00591320800861933,0.00347086462787926,-0.0127161026792627,0.000889686662024021,0.0884501089202627
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23124.Arm fat mass (left),42247,-0.00223827207806108,0.00334857872958354,-0.00880148638804481,0.00432494223192266,0.503866311033164
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23125.Arm fat-free mass (left),42243,0.00559452500856942,0.00272190678263388,0.000259587714607016,0.0109294623025318,0.0398494355484611
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23126.Arm predicted mass (left),42240,0.00579657987785714,0.00273188191844846,0.000442091317698163,0.0111510684380161,0.0338581038493187
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23127.Trunk fat percentage,42238,-0.00357834490590559,0.00218189878413806,-0.00785486652281619,0.000698176711005012,0.101009671482438
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23128.Trunk fat mass,42234,-0.00177255887770022,0.00240304443392537,-0.00648252596819394,0.00293740821279351,0.460743112853495
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23129.Trunk fat-free mass,42228,0.00611272175828453,0.00240488201352618,0.00139915301177321,0.0108262905047958,0.0110319657878688
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23130.Trunk predicted mass,42223,0.00600954536903624,0.00240790474062854,0.00129005207740431,0.0107290386606682,0.0125726494567055
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23400.Total Cholesterol,24016,0.00328002765668384,0.00175189850740175,-0.000153693417823592,0.00671374873119128,0.0611813579157889
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,24016,0.00223596435256649,0.00169480864515214,-0.0010858605919317,0.00555778929706467,0.187080770773683
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",24016,0.00124808362065559,0.00169707869871822,-0.00207819062883212,0.00457435787014329,0.462084472149816
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23403.VLDL Cholesterol,24016,-0.00060162351395445,0.00169629725009141,-0.00392636612413361,0.0027231190962247,0.722840929957853
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23404.Clinical LDL Cholesterol,24016,0.00322089720540874,0.00169592522226566,-0.00010311623023196,0.00654491064104945,0.0575504708666941
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23405.LDL Cholesterol,24016,0.0030445099676031,0.00169126821533701,-0.000270375734457435,0.00635939566966363,0.0718519822035964
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23406.HDL Cholesterol,24016,0.00482028014530362,0.00197313148810457,0.000952942428618667,0.00868761786198858,0.0145745327468312
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23407.Total Triglycerides,24016,-0.00309635539536181,0.00179212959419196,-0.00660892939997806,0.000416218609254428,0.0840455689588463
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23408.Triglycerides in VLDL,24016,-0.00293948493923895,0.00180513920954965,-0.00647755778995626,0.000598587911478362,0.103453662179393
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23409.Triglycerides in LDL,24016,-0.00186598917104317,0.00174206365846303,-0.00528043394163071,0.00154845559954438,0.284118518938564
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23410.Triglycerides in HDL,24016,-0.00483198794354523,0.00172495142299838,-0.00821289273262206,-0.00145108315446841,0.00509487448340578
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,24016,0.00186254826894792,0.00177792226642529,-0.00162217937324565,0.00534727591114148,0.294834289318468
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23412.Phospholipids in VLDL,24016,-0.00168544600792967,0.00173430108820141,-0.00508467614080443,0.0017137841249451,0.331144869844971
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23413.Phospholipids in LDL,24016,0.00293622495900708,0.00168773844698944,-0.000371742397092229,0.00624419231510638,0.081917617736257
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23414.Phospholipids in HDL,24016,0.00214367432944424,0.00189659712991092,-0.00157365604518117,0.00586100470406966,0.258372102180776
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23415.Total Esterified Cholesterol,24016,0.00356619225617461,0.00176103492819424,0.000114563796913896,0.00701782071543532,0.0428727829417558
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,24016,-0.000170225480602057,0.00168689517503677,-0.00347654002367412,0.00313608906247001,0.919622329528069
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23417.Cholesteryl Esters in LDL,24016,0.00270244663634731,0.00168776383281361,-0.000605570475967366,0.00601046374866198,0.109345895701585
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23418.Cholesteryl Esters in HDL,24016,0.00504641231074807,0.00196594807005642,0.00119315409343748,0.00889967052805865,0.0102669204943786
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23419.Total Free Cholesterol,24016,0.00254012684322864,0.00172996388431122,-0.000850602370021353,0.00593085605647863,0.142032579653849
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23420.Free Cholesterol in VLDL,24016,-0.00117173410687226,0.00171840309031362,-0.00453980416388695,0.00219633595014243,0.495325310373181
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23421.Free Cholesterol in LDL,24016,0.00386107354717944,0.00170740564957685,0.000514558474008822,0.00720758862035006,0.0237453509339205
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23422.Free Cholesterol in HDL,24016,0.00362873229758101,0.00197074325758423,-0.00023392448728408,0.00749138908244611,0.0655897367591164
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,24016,0.00134143862162216,0.00171563471590951,-0.00202120542156048,0.00470408266480481,0.434286594832206
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23424.Total Lipids in VLDL,24016,-0.00202904756554096,0.00175563122413481,-0.00547008476484519,0.00141198963376328,0.247800346189296
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23425.Total Lipids in LDL,24016,0.00276543518062523,0.00168932201842643,-0.000545635975490578,0.00607650633674105,0.101641719538993
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23426.Total Lipids in HDL,24016,0.0029185214646026,0.00192590860805642,-0.000856259407187988,0.00669330233639318,0.129684363738041
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,24016,0.00347657166395338,0.0018099423790147,-7.09153989154406e-05,0.0070240587268222,0.0547663661231802
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23428.Concentration of VLDL Particles,24016,-0.00128847863947383,0.00171001148650938,-0.00464010115303221,0.00206314387408455,0.451162176923128
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23429.Concentration of LDL Particles,24016,0.00190456123822891,0.00168232366207337,-0.00139279313943489,0.00520191561589271,0.25760304993066
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23430.Concentration of HDL Particles,24016,0.00339145428908099,0.00181491723309975,-0.000165783487794526,0.0069486920659565,0.0616829902154876
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23431.Average Diameter for VLDL Particles,24016,-0.00235754954242208,0.00187400556390418,-0.00603060044767428,0.00131550136283011,0.20839424061169
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23432.Average Diameter for LDL Particles,24016,0.00620999565166672,0.00175357773187332,0.00277298329719501,0.00964700800613842,0.000398871011759318
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23433.Average Diameter for HDL Particles,24016,0.00185172532682501,0.00200713633107457,-0.00208226188208115,0.00578571253573118,0.356240203411698
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23434.Phosphoglycerides,23994,0.00131066405666166,0.00178868892813168,-0.00219516624247644,0.00481649435579976,0.46371731875606
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,23994,-0.00465987449314775,0.00190411849923492,-0.00839194675164819,-0.000927802234647311,0.0144017881231123
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23436.Total Cholines,23994,0.00205500563692585,0.00180595075205773,-0.0014846578371073,0.00559466911095901,0.25517030884191
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23437.Phosphatidylcholines,23994,0.00168517528744072,0.00181188030571705,-0.00186611011176469,0.00523646068664614,0.352344270126126
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23438.Sphingomyelins,23993,0.00435865160291521,0.00181881646896281,0.000793771323748095,0.00792353188208232,0.0165636328157704
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23439.Apolipoprotein B,24016,0.00164734291230504,0.00168523351767987,-0.00165571478234751,0.00495040060695758,0.32832355827705
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23440.Apolipoprotein A1,24016,0.00267844366809503,0.00187438722566381,-0.000995355294206042,0.0063522426303961,0.15302578488068
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,24016,0.000287017305327535,0.00171524498210452,-0.00307486285959732,0.00364889747025239,0.867109350212591
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23442.Total Fatty Acids,23994,-0.00101563899652848,0.00171787792494388,-0.00438267972941848,0.00235140173636152,0.554380464534685
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23443.Degree of Unsaturation,23994,0.0016239276339031,0.00184322974847219,-0.00198880267310239,0.0052366579409086,0.378314250809569
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23444.Omega-3 Fatty Acids,23994,-0.00124007126669289,0.00174340216430664,-0.0046571395087339,0.00217699697534811,0.476909070102084
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23445.Omega-6 Fatty Acids,23994,0.000734036755192171,0.00172060746189027,-0.00263835387011275,0.0041064273804971,0.669663683600618
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,23994,0.000484319117382187,0.00172970814777957,-0.00290590885226578,0.00387454708703015,0.779479549221667
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23447.Monounsaturated Fatty Acids,23994,-0.00235277910003533,0.00175686979037943,-0.00579624388917901,0.00109068568910835,0.180522141587103
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23448.Saturated Fatty Acids,23994,-0.000920394833982741,0.00172584383282634,-0.00430304874632237,0.00246225907835689,0.59382994059111
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23449.Linoleic Acid,23994,0.000667563015887085,0.00171320767927171,-0.00269032403548546,0.00402545006725963,0.696793808075095
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23450.Docosahexaenoic Acid,23994,0.0021756883262558,0.0017927977352504,-0.00133819523483498,0.00568957188734659,0.224923329348019
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,23994,-0.00110277521602179,0.00175277084226717,-0.00453820606686544,0.00233265563482186,0.529249591952235
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,23994,0.00315277147129112,0.00182921891690953,-0.00043249760585157,0.00673804054843381,0.0847999068233242
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,23994,0.00314424463321884,0.00186129093936148,-0.000503885607929667,0.00679237487436734,0.0911784676811685
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,23994,-0.00459744296537451,0.00189939297279317,-0.00832025319204913,-0.000874632738699895,0.0155074051664032
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,23994,-0.000302306563841921,0.00171776227081227,-0.00366912061463396,0.00306450748695012,0.860304390698613
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,23994,0.00305070462753477,0.00182433307652518,-0.000524988202454581,0.00662639745752412,0.094492009019088
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,23994,0.0029302681532789,0.00179649080431131,-0.000590853823171269,0.00645139012972908,0.102880943198942
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,23994,0.00415755087305025,0.00189688835106725,0.00043964970495845,0.00787545204114206,0.0284053988872165
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,23992,0.00192409422847531,0.00173589168636784,-0.00147825347680565,0.00532644193375627,0.267692293859027
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23460.Alanine,24007,-0.0014803742478654,0.00171030269626659,-0.00483256753254792,0.00187181903681713,0.386738663400811
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23461.Glutamine,23937,0.00259806655171456,0.00170338937356695,-0.000740576620476662,0.00593670972390578,0.127214084627824
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23462.Glycine,23986,0.00492547798322707,0.00178844110943654,0.00142013340873144,0.00843082255772269,0.00589049414122383
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23463.Histidine,23985,0.00129953072707891,0.00168517078937132,-0.00200340402008888,0.00460246547424669,0.440621663304013
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),23997,-0.000531875422591377,0.00178977245793778,-0.00403982944014942,0.00297607859496667,0.766335569563459
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23465.Isoleucine,24011,-0.000348410561419027,0.00174483213801491,-0.00376828155192826,0.0030714604290902,0.841731436647309
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23466.Leucine,24012,0.000290326995158346,0.00178014738031971,-0.00319876187026828,0.00377941586058497,0.870447726268595
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23467.Valine,23997,-0.000903953319280269,0.00179615661042275,-0.00442442027570886,0.00261651363714832,0.614778458391262
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23468.Phenylalanine,24006,0.000312363537921364,0.00170027976741002,-0.00302018480620228,0.00364491188204501,0.854240143567276
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23469.Tyrosine,23987,-0.000516347785811058,0.00174048675206852,-0.00392770181986535,0.00289500624824323,0.766722094201302
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23470.Glucose,23974,0.00234828299449017,0.00172178765860659,-0.00102642081637874,0.00572298680535908,0.172623406140805
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23471.Lactate,23974,2.84873468220157e-05,0.00170976377433759,-0.00332264965087967,0.0033796243445237,0.986706745256058
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23472.Pyruvate,23936,0.0019355566624288,0.00169646736237269,-0.00138951936782168,0.00526063269267928,0.253908965718269
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23473.Citrate,24013,0.0043276000208907,0.00171636969285518,0.000963515422894553,0.00769168461888684,0.0116963660401489
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23474.3-Hydroxybutyrate,23628,0.000946858123540452,0.00173098388701949,-0.00244587029501775,0.00433958654209866,0.584379957059847
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23475.Acetate,23996,0.00464156026470644,0.00168680255626223,0.00133542725443247,0.00794769327498041,0.00593328621388018
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23476.Acetoacetate,24015,-0.000839027363346342,0.00170048751710179,-0.00417198289686586,0.00249392817017318,0.621731662646583
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23477.Acetone,24015,0.00293695700447758,0.0016962791803381,-0.000387750188985091,0.00626166419794026,0.0833912761172627
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23478.Creatinine,23428,0.00176771831071562,0.00204554195268236,-0.00224154391654181,0.00577698053797304,0.387497368992025
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23479.Albumin,24012,0.00444521095379456,0.00171659865624946,0.00108067758754562,0.00780974432004351,0.00961606509338602
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23480.Glycoprotein Acetyls,24016,-0.00336244149769397,0.00180712111115274,-0.00690439887555334,0.000179515880165403,0.0628041495703689
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,24016,-0.00439833347269532,0.00181315047039993,-0.00795210839467919,-0.000844558550711457,0.0152821678734677
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,24016,-0.00429537823412472,0.00180899563992597,-0.00784100968837963,-0.000749746779869818,0.0175827077090956
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,24016,-0.00481702041317452,0.00182241289259051,-0.00838894968265192,-0.00124509114369713,0.00821773674974939
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,24016,-0.00430204668671573,0.00180236361841929,-0.00783467937881754,-0.000769413994613914,0.0169991935744252
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,24016,-0.00350549925860133,0.00179377770742576,-0.00702130356515582,1.03050479531505e-05,0.0506826494701479
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,24016,-0.00469139703469705,0.00180476721356336,-0.00822874077328124,-0.00115405329611286,0.00934311936139274
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,24016,-0.00358953683029366,0.00180200181683037,-0.00712146039128118,-5.76132693061366e-05,0.0463854606305913
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,24016,-0.0031127907556221,0.00181887105659464,-0.0066777780265476,0.000452196515303401,0.0870227698861237
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,24016,-0.00290213477737353,0.00181635975582535,-0.0064621998987912,0.000657930344044148,0.110106154280909
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,24016,-0.00292780870602237,0.00180790251379518,-0.00647129763306092,0.000615680221016178,0.105363497592965
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,24016,-0.00230823439735685,0.00176992741826157,-0.00577729213714952,0.00116082334243583,0.192198117320188
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,24016,-0.00161942137795468,0.00174585500131731,-0.00504129718053661,0.00180245442462726,0.35363444794589
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,24016,-0.00294244996094112,0.00179276198877714,-0.00645626345894431,0.000571363537062062,0.100749449053126
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,24016,-0.00313091863374934,0.00183338493026839,-0.00672435309707539,0.000462515829576713,0.087700175762412
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23495.Concentration of Large VLDL Particles,24016,-0.00243924489066845,0.0017968306230004,-0.00596103291174923,0.00108254313041234,0.17462679465094
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23496.Total Lipids in Large VLDL,24016,-0.00203582922261851,0.00179250293669496,-0.00554913497854064,0.00147747653330361,0.256073947033864
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23497.Phospholipids in Large VLDL,24016,-0.00256126971147434,0.00180316335090794,-0.00609546987925391,0.000972930456305228,0.155495137494846
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23498.Cholesterol in Large VLDL,24016,-0.00202263377086544,0.00176052432151902,-0.00547326144104273,0.00142799389931184,0.25061630806862
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,24016,-0.00151350007992591,0.00172897933516599,-0.00490229957685126,0.00187529941699944,0.381380295214303
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,24016,-0.00249568347092104,0.00179482846754909,-0.00601354726731726,0.00102218032547518,0.164394305146297
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23501.Triglycerides in Large VLDL,24016,-0.00184213186429053,0.00179822182075026,-0.00536664663296105,0.00168238290437999,0.305647928717384
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,24016,0.000167011543376272,0.00169493588695679,-0.00315506279505904,0.00348908588181158,0.921507818809422
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23503.Total Lipids in Medium VLDL,24016,-9.26078928857647e-05,0.00170825055498874,-0.0034407789806637,0.00325556319489217,0.956766611607595
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23504.Phospholipids in Medium VLDL,24016,0.000374694417885695,0.00169159446821883,-0.00294083073982322,0.00369021957559461,0.824702147542437
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23505.Cholesterol in Medium VLDL,24016,0.00177100213732048,0.00168756125407307,-0.00153661792066274,0.0050786221953037,0.293984081690565
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,24016,0.00242708371063027,0.00170382788052012,-0.000912418935189156,0.0057665863564497,0.154318029898733
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,24016,0.000819689171381107,0.00168511837042003,-0.00248314283464215,0.00412252117740436,0.626668009972558
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23508.Triglycerides in Medium VLDL,24016,-0.00145146914411297,0.00176819072722271,-0.00491712296946949,0.00201418468124355,0.411723827151843
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23509.Concentration of Small VLDL Particles,24016,-0.00169054764159367,0.00172849883675054,-0.00507840536162472,0.00169731007843739,0.328062498814366
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23510.Total Lipids in Small VLDL,24016,-0.00147306659109066,0.00172249888666916,-0.00484916440896222,0.0019030312267809,0.392453618034752
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23511.Phospholipids in Small VLDL,24016,-0.000103029403159739,0.00169513912831842,-0.00342550209466384,0.00321944328834436,0.951535466328594
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23512.Cholesterol in Small VLDL,24016,-6.72693031840584e-05,0.00168962844907734,-0.00337894106337565,0.00324440245700753,0.968242483748088
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,24016,-0.000638969222689381,0.00169594812113319,-0.00396302754011043,0.00268508909473166,0.7063536307999
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,24016,0.000891860907128856,0.00168386762681605,-0.00240851964143061,0.00419224145568832,0.596359347142488
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23515.Triglycerides in Small VLDL,24016,-0.00337534063136435,0.00177308614243895,-0.00685058947054468,9.99082078159842e-05,0.0569673489226314
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,24016,-0.000960639696393707,0.00170695298885764,-0.00430626755455469,0.00238498816176728,0.573589680570818
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,24016,-0.0010641387852077,0.0017112846035021,-0.00441825660807182,0.00228997903765642,0.534055459610158
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,24016,-0.00146034003485866,0.00170717386882782,-0.00480640081776119,0.00188572074804387,0.392330661939177
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,24016,0.000378849828415718,0.00173443789054709,-0.00302064843705658,0.00377834809388802,0.827097495415504
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,24016,0.000847000627376103,0.00174852349393174,-0.00258010542073011,0.00427410667548232,0.628100007805608
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,24016,-0.000674880649020207,0.00171082420349646,-0.00402809608787327,0.00267833478983285,0.693232474489051
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,24016,-0.00366312085370489,0.00174598512201835,-0.00708525169286085,-0.000240990014548924,0.0359133430715408
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23523.Concentration of IDL Particles,24016,0.00199659000947403,0.00170728993760208,-0.00134969826822605,0.0053428782871741,0.242234037091338
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23524.Total Lipids in IDL,24016,0.00272708083942348,0.00175229569305492,-0.000707418718964168,0.00616158039781113,0.119652254815205
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23525.Phospholipids in IDL,24016,0.00236708077240563,0.0017523313806227,-0.00106748873361485,0.00580165027842612,0.176766474424957
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23526.Cholesterol in IDL,24016,0.00331730949844625,0.00175975575883242,-0.000131811788865291,0.0067664307857578,0.0594288736522831
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23527.Cholesteryl Esters in IDL,24016,0.00350244484031101,0.00176029380825139,5.22689761382768e-05,0.00695262070448374,0.0466360563900149
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23528.Free Cholesterol in IDL,24016,0.00267323119334649,0.00175463411879938,-0.000765851679500299,0.00611231406619328,0.127640265375238
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23529.Triglycerides in IDL,24016,-0.00256488950447812,0.00173236055014466,-0.00596031618276165,0.000830537173805405,0.138733020598561
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23530.Concentration of Large LDL Particles,24016,0.00276793232234953,0.00168566890399657,-0.000535978729483744,0.00607184337418281,0.100595238715185
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23531.Total Lipids in Large LDL,24016,0.00318401192719866,0.00170258212668468,-0.000153049041103308,0.00652107289550063,0.0614810274538169
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23532.Phospholipids in Large LDL,24016,0.00307954355109428,0.00169986057128821,-0.00025218316863062,0.00641127027081918,0.0700535922835956
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23533.Cholesterol in Large LDL,24016,0.0035302370001751,0.00170646634370006,0.000185562966522982,0.00687491103382723,0.0385810731364114
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,24016,0.00337795660631405,0.00170045884555959,4.50572690172436e-05,0.00671085594361085,0.0469895045122958
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23535.Free Cholesterol in Large LDL,24016,0.00388402674450988,0.00172569053999725,0.000501673286115257,0.00726638020290449,0.0244130048671347
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23536.Triglycerides in Large LDL,24016,-0.00165795431556109,0.00173508106003543,-0.00505871319323053,0.00174280456210835,0.339309953131189
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23537.Concentration of Medium LDL Particles,24016,0.000325640681847646,0.00168282178809583,-0.00297269002282019,0.00362397138651548,0.846562218875404
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23538.Total Lipids in Medium LDL,24016,0.00199826575094922,0.00168349587909112,-0.00130138617206938,0.00529791767396782,0.235249644121286
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23539.Phospholipids in Medium LDL,24016,0.00252023772956172,0.00168150838959647,-0.000775518714047363,0.00581599417317081,0.133939763305559
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23540.Cholesterol in Medium LDL,24016,0.00206855560409192,0.00168195240442663,-0.00122807110858427,0.00536518231676811,0.218763901233844
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,24016,0.00144811482213653,0.00168647516266201,-0.001857376496681,0.00475360614095407,0.390534717065912
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,24016,0.00363374578947874,0.00168464365800207,0.000331844219794692,0.0069356473591628,0.0310169746213845
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23543.Triglycerides in Medium LDL,24016,-0.00181760376833329,0.00175165765560891,-0.00525085277332674,0.00161564523666017,0.299444493851969
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23544.Concentration of Small LDL Particles,24016,0.000888296837556818,0.00168232913367082,-0.00240906826443799,0.00418566193955162,0.597493055406738
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23545.Total Lipids in Small LDL,24016,0.00225068149161714,0.00168268081554608,-0.00104737290685319,0.00554873589008746,0.181053565762241
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23546.Phospholipids in Small LDL,24016,0.00292236095990581,0.00168220370346862,-0.000374758298892689,0.00621948021870431,0.0823608547881771
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23547.Cholesterol in Small LDL,24016,0.00237485417459713,0.00168054957946107,-0.000919023001146563,0.00566873135034083,0.157627122026237
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,24016,0.00167100048466587,0.0016845323575268,-0.00163068293608665,0.0049726839054184,0.321223630445887
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23549.Free Cholesterol in Small LDL,24016,0.00400918127097118,0.00168337224626086,0.00070977166829989,0.00730859087364246,0.0172436346622075
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23550.Triglycerides in Small LDL,24016,-0.00273664615444482,0.00176791662747307,-0.00620176274429204,0.000728470435402403,0.121647572369706
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,24016,0.00243669717194258,0.00197369041131013,-0.00143173603422528,0.00630513037811044,0.216995459158343
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23552.Total Lipids in Very Large HDL,24016,0.0025217021809115,0.001980001657205,-0.0013591010672103,0.0064025054290333,0.202822547148847
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23553.Phospholipids in Very Large HDL,24016,0.00208232141231707,0.00197260643756467,-0.00178398720530969,0.00594863002994383,0.291152808206133
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23554.Cholesterol in Very Large HDL,24016,0.00356862099083467,0.00198686024217334,-0.000325625083825083,0.00746286706549442,0.0724894802537671
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,24016,0.00392269086059579,0.00201081149364919,-1.84996669566105e-05,0.0078638813881482,0.0510924741776005
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,24016,0.0024878982458479,0.00188016470832668,-0.00119722458247239,0.0061730210741682,0.185770110316651
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23557.Triglycerides in Very Large HDL,24016,-0.00312625729455418,0.00170499373449479,-0.00646804501416396,0.000215530425055602,0.0667274422148699
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23558.Concentration of Large HDL Particles,24016,0.00353048299325861,0.00204946895065265,-0.000486476150020585,0.00754744213653781,0.0849677818538147
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23559.Total Lipids in Large HDL,24016,0.0034512775353111,0.00203368715077868,-0.000534749280215108,0.00743730435083731,0.0896993591588474
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23560.Phospholipids in Large HDL,24016,0.00305928209139825,0.00200853412207498,-0.000877444787868718,0.00699600897066521,0.127736430670943
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23561.Cholesterol in Large HDL,24016,0.00431183957726681,0.00204969750096602,0.000294432475373411,0.0083292466791602,0.0354196464273991
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,24016,0.004546544056169,0.00205005878877657,0.000528428830166917,0.00856465928217108,0.02658033896439
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23563.Free Cholesterol in Large HDL,24016,0.00345810210469187,0.00203530518075542,-0.000531096049588747,0.00744730025897248,0.0893211635505646
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23564.Triglycerides in Large HDL,24016,-0.00410633100897072,0.0017384293432736,-0.00751365252178697,-0.000699009496154466,0.0181800403559293
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23565.Concentration of Medium HDL Particles,24016,0.0023948404757674,0.00185546889411343,-0.00124187855669493,0.00603155950822972,0.196822629589123
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23566.Total Lipids in Medium HDL,24016,0.00195145032792705,0.00183144315590046,-0.00163817825763784,0.00554107891349194,0.286648677634663
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23567.Phospholipids in Medium HDL,24016,0.0012909168658554,0.00180914823259457,-0.00225501367002996,0.00483684740174075,0.475512715154078
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23568.Cholesterol in Medium HDL,24016,0.00356172495484605,0.0018700952062427,-0.00010366164938964,0.00722711155908174,0.0568480898752377
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,24016,0.00365377061881013,0.00186320800351436,1.88293192199046e-06,0.00730565830569826,0.049889333460691
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,24016,0.00301748008310035,0.00188735714571391,-0.000681739922498912,0.00671670008869962,0.109881335080903
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23571.Triglycerides in Medium HDL,24016,-0.00489944311987822,0.00172556239050149,-0.00828154540526115,-0.0015173408344953,0.00452461878399821
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23572.Concentration of Small HDL Particles,24016,0.00262739428776747,0.00168479099253205,-0.000674796057595339,0.00592958463313028,0.118896499959339
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23573.Total Lipids in Small HDL,24016,0.00125037941475253,0.00169730792211432,-0.00207634411259154,0.00457710294209661,0.461321801821002
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23574.Phospholipids in Small HDL,24016,0.000732836387621797,0.0017052747890018,-0.00260950219882174,0.00407517497406533,0.66738369192177
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23575.Cholesterol in Small HDL,24016,0.0032634207062115,0.00168533704919613,-3.9839910212911e-05,0.0065666813226359,0.0528352431949807
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,24016,0.00348261513263243,0.00167738124340822,0.000194947895552312,0.00677028236971255,0.0378840797346894
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23577.Free Cholesterol in Small HDL,24016,0.0020225143958613,0.00171930021196559,-0.00134731401959126,0.00539234281131386,0.239463087574821
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23578.Triglycerides in Small HDL,24016,-0.00475967979586338,0.00180941130301725,-0.0083061259497772,-0.00121323364194956,0.00853105640786378
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,22978,-0.00275079663637529,0.00171371062897845,-0.00610966946917304,0.000608076196422469,0.108470180896555
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,22978,0.00189934022155393,0.00173424764588117,-0.00149978516437315,0.00529846560748102,0.273442481941542
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,22978,0.00215229493385196,0.00171778182093388,-0.00121455743517843,0.00551914730288236,0.210236618963769
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,22978,0.000217505209336328,0.0017495501136438,-0.00321161301340552,0.00364662343207818,0.901062485018247
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,22978,3.16232244326465e-05,0.0017090123168447,-0.00331804091658296,0.00338128736544826,0.985237105794241
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,23756,-0.00119770100150982,0.00167438266456119,-0.00447949102404976,0.00208408902103011,0.474425158066981
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,23756,0.00300725900598335,0.00183250662088489,-0.000584453970951039,0.00659897198291774,0.100797562195649
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,23756,0.00334736092853144,0.0018310215565722,-0.00024144132235007,0.00693616317941294,0.0675413155807467
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,23756,0.00151806397848365,0.00177439254602239,-0.00195974541172023,0.00499587336868754,0.392260847671027
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,23756,-0.00273550211817629,0.00178763536991803,-0.00623926744321562,0.000768263206863047,0.12597190651126
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,24011,-0.00420478489894395,0.00178556227717051,-0.00770448696219815,-0.000705082835689748,0.0185366952505108
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,24011,0.000171087918901308,0.00172495369185159,-0.00320982131712781,0.00355199715493042,0.920992955316919
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,24011,0.00134697410501179,0.0017880174815884,-0.00215754015890147,0.00485148836892505,0.451256709307391
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,24011,-0.00221521792828369,0.00168884330976178,-0.00552535081541679,0.00109491495884941,0.189641488522332
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,24011,0.0014547531856503,0.00167202536196596,-0.00182241652380298,0.00473192289510359,0.384279325540495
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,24016,0.00264426076139956,0.00176820505273186,-0.000821421141954893,0.00610994266475401,0.134810406059643
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,24016,0.003987239,0.001844772,0.0003714858,0.007602992,0.03067646
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,24016,0.00420944568671183,0.00185773979534262,0.000568275687840288,0.00785061568558336,0.0234666013474868
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,24016,0.00318166610559046,0.00180146408263813,-0.000349203496380279,0.00671253570756119,0.0773824362126758
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,24016,-0.00377621424814837,0.00182959774623493,-0.00736222583076884,-0.000190202665527898,0.039032351582057
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,24016,0.00578813294219627,0.00179888182862758,0.00226232455808621,0.00931394132630633,0.00129426751645941
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,24016,0.00385650821452555,0.00174327340310921,0.000439692344431501,0.0072733240846196,0.0269606916058451
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,24016,0.00224292750526166,0.00170124640512157,-0.00109151544877662,0.00557737045929995,0.187381526464996
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,24016,0.00568839153085235,0.00180927556432478,0.00214221142477579,0.00923457163692892,0.00166849322105504
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,24016,-0.0044929505883246,0.00176082251161719,-0.00794416271109429,-0.00104173846555491,0.0107284710148376
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,24016,-0.00361026493964649,0.00175977797440445,-0.00705942976947921,-0.00016110010981378,0.0402246612567303
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,24016,0.00465148238513997,0.00183525401210773,0.00105438452140882,0.00824858024887113,0.0112665475608124
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,24016,0.00489548776911925,0.0018536396746528,0.00126235400679975,0.00852862153143874,0.00827119080211237
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,24016,0.00210777298348657,0.00170048274998797,-0.00122517320648985,0.00544071917346299,0.215167150627825
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,24016,-0.00429048247771795,0.00182150650612379,-0.00786063522972058,-0.000720329725715311,0.0185078770839931
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,24016,-0.00296903396582917,0.00168638696935469,-0.00627435242576435,0.000336284494106018,0.078320763867404
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,24016,0.0050543465470167,0.00176984176251953,0.00158545669247843,0.00852323640155498,0.00429628938481151
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,24016,0.0057594849743327,0.0017629485862614,0.00230410574526035,0.00921486420340505,0.00108861091000354
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,24016,0.00086176070968373,0.00171340058079459,-0.00249650442867366,0.00422002584804112,0.615001625190015
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,24016,-0.00536275548772259,0.00180210299001544,-0.00889487734815285,-0.00183063362729232,0.00292486139625672
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,24016,-0.00176468218985097,0.00169209480125278,-0.00508118800030641,0.00155182362060447,0.297006065633233
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,24016,0.00705081970742356,0.0017968778302778,0.00352893916007908,0.010572700254768,8.73593939370258e-05
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,24016,0.00462143542118413,0.00167809498895754,0.00133236924282735,0.0079105015995409,0.0058920165362339
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,24016,0.00426567357984806,0.00185079232911882,0.000638120614775172,0.00789322654492094,0.0211872546341515
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,24016,-0.00569453591190571,0.00177238554967145,-0.00916841158926175,-0.00222066023454966,0.00131565535461095
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,24016,0.00425320175960423,0.00169184278045273,0.000937189909916876,0.00756921360929158,0.0119453530259016
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,24016,0.0020606319222283,0.00170878079482243,-0.00128857843562367,0.00540984228008026,0.227864967507312
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,24016,-0.00292150523552306,0.00172607350780152,-0.00630460931081405,0.00046159883976793,0.0905497722856412
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,24016,0.00572964165431565,0.00183680288219607,0.00212950800521136,0.00932977530341994,0.00181461527188968
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,24016,-0.00492119373806033,0.00173517310666879,-0.00832213302713115,-0.0015202544489895,0.00457006403040734
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,24016,0.00201490993915491,0.00170216465858684,-0.00132133279167529,0.00535115266998511,0.23653015468229
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,24016,0.00220078305561258,0.00169179257491319,-0.00111513039121727,0.00551669650244243,0.19331932029117
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,24016,-0.00221348455446294,0.00170103523531575,-0.00554751361568181,0.00112054450675593,0.193182880931576
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,24016,0.00583089356550697,0.00177229606916006,0.00235719326995325,0.00930459386106069,0.00100323771143842
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,24016,-0.00568958033444564,0.0017779016531112,-0.00917426757454359,-0.00220489309434769,0.00137527111443298
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,24004,-0.000412385599107792,0.00189332462819808,-0.00412330187037603,0.00329853067216045,0.827578774006736
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,24004,0.00317044927777956,0.00176586852254216,-0.000290653026403062,0.00663155158196219,0.0726017681108555
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,24004,0.00511583945723186,0.00170116660251463,0.00178155291630318,0.00845012599816053,0.00263892754879554
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,24004,-0.00173196070509145,0.00200194886748301,-0.00565578048535815,0.00219185907517525,0.386972066659888
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,24004,-0.00477617485049318,0.00187414185276355,-0.00844949288190974,-0.00110285681907662,0.0108261558974435
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,24016,-0.00402502847986594,0.00186670343189509,-0.00768376720638032,-0.000366289753351555,0.0310761756389661
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,24016,0.00703649900231297,0.0019154998263619,0.00328211934264364,0.0107908786619823,0.000239814470325255
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,24016,0.00670135238746504,0.00188485214939024,0.00300704217466017,0.0103956626002699,0.000378168936421223
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,24016,0.0029452075784456,0.00184666544912002,-0.000674256701829642,0.00656467185872084,0.11075250716232
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,24016,-0.00673750232761363,0.00184694600493769,-0.0103575164972915,-0.00311748815793576,0.000264936529891162
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,24016,-0.00601762946310372,0.00188858165244707,-0.00971924950189997,-0.00231600942430746,0.00144278507595956
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,24016,0.00683137311527042,0.00185650509847131,0.00319262312226665,0.0104701231082742,0.000234023430775012
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,24016,0.00626322056179675,0.001802280142559,0.00273075148238111,0.0097956896412124,0.000511440938235166
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,24016,0.00524466440882029,0.00198315714384022,0.00135767640689346,0.00913165241074711,0.00818399030894129
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,24016,-0.0068239225978349,0.0018124154737831,-0.0103762569264498,-0.00327158826922002,0.000166880373823815
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,24016,-0.00351485554590628,0.00172034445989514,-0.00688673068730076,-0.000142980404511794,0.0410523000407923
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,24016,0.0063951294730853,0.00172278140741207,0.00301847791455763,0.00977178103161296,0.000206014774347143
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,24016,0.0054964393787829,0.00170950927077207,0.00214580120806965,0.00884707754949615,0.00130519464727263
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,24016,0.00279955725446815,0.00180902834986632,-0.000746138311269839,0.00634525282020615,0.121744470123525
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,24016,-0.00645371201066195,0.00184298425816999,-0.0100659611566751,-0.00284146286464877,0.000463013230030515
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,42534,0.00156223285679888,0.00145245396224837,-0.00128457690920792,0.00440904262280569,0.282120492204565
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,42534,0.0016261615761622,0.00141976796567507,-0.00115658363656093,0.00440890678888533,0.252061800472556
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,39519,-0.000191959275170387,0.00135311874504599,-0.00284407201546053,0.00246015346511976,0.88718789849863
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,39519,0.00215648956955758,0.0014771139651982,-0.000738653802230901,0.00505163294134606,0.144316041005434
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,39519,0.00127969728456211,0.00145122160981285,-0.00156469707067108,0.0041240916397953,0.377886584062898
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,39519,0.000118069267315771,0.00133460039605598,-0.00249774750895394,0.00273388604358548,0.929505260916845
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24009.Traffic intensity on the nearest road,42534,0.163204339756756,0.0738733541730006,0.0184125655776752,0.307996113935838,0.0271629136856162
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24010.Inverse distance to the nearest road,42534,-0.00104238589769396,0.00127511837739836,-0.00354161791739476,0.00145684612200683,0.413657802048332
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24011.Traffic intensity on the nearest major road,42534,-0.000555133961355271,0.00126986498885955,-0.00304406933952,0.00193380141680945,0.661997660538004
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24012.Inverse distance to the nearest major road,42534,0.00160059601194061,0.00129561805105459,-0.00093881536812639,0.00414000739200761,0.216691521315433
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24013.Total traffic load on major roads,42534,0.0960823615710412,0.0526020247878351,-0.0070176070131155,0.199182330155198,0.0677683624656226
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24015.Sum of road length of major roads within 100m,42534,0.0672111362495917,0.0512041124719727,-0.0331489241954749,0.167571196694658,0.189320784072616
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,42534,0.000903463057600021,0.00145325290974079,-0.00194491264549192,0.00375183876069197,0.534153471113872
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,42534,0.00116330682616719,0.00145170355885904,-0.00168203214919653,0.00400864580153092,0.422939837656915
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,42534,0.00115372356366995,0.00143648239366175,-0.00166178192790708,0.00396922905524698,0.421887409345647
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,42442,0.00101509040880199,0.00140813613694735,-0.00174485641961481,0.00377503723721879,0.470990278953001
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24020.Average daytime sound level of noise pollution,42534,0.000382396021957313,0.00127615480187625,-0.00211886738972014,0.00288365943363477,0.764447856062476
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24021.Average evening sound level of noise pollution,42534,0.000395325070361741,0.00127624737702987,-0.00210611978861681,0.0028967699293403,0.756748158216088
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24022.Average night-time sound level of noise pollution,42534,0.000379227626579935,0.00127613646649511,-0.00212199984775049,0.00288045510091036,0.766339281069328
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24023.Average 16-hour sound level of noise pollution,42534,0.000395694682271136,0.00127619891481266,-0.00210565519076168,0.00289704455530395,0.756518966422433
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24024.Average 24-hour sound level of noise pollution,42534,0.000392937664152903,0.00127624136722132,-0.00210849541560089,0.00289437074390669,0.758170101464478
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2405.Number of children fathered,19528,-0.0150029759947552,0.0589683227239261,-0.13058088853365,0.10057493654414,0.799170437546513
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",37681,-0.000522015285233887,0.00149174120810495,-0.00344582805311959,0.00240179748265182,0.726388014422257
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",37681,-0.000819872653531418,0.00135040490374999,-0.0034666662648814,0.00182692095781856,0.543767651234465
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24502.Water percentage, buffer 1000m",37681,-0.00186626635893469,0.00134079967729687,-0.00449423372643657,0.000761701008567183,0.16395925404157
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24503.Greenspace percentage, buffer 300m",37681,-0.000325623160124886,0.00140282837569779,-0.00307516677649255,0.00242392045624278,0.816446826638531
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",37681,-0.000891382711325707,0.00136457224204387,-0.0035659443057317,0.00178317888308028,0.513610494784578
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24505.Water percentage, buffer 300m",37681,-0.000803854001323036,0.00135170794294156,-0.0034532015694885,0.00184549356684243,0.552050913919912
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",42742,-0.000754073669217593,0.00142628547140777,-0.00354959319317682,0.00204144585474164,0.597018006210767
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24507.Natural environment percentage, buffer 300m",42742,-0.000746277413757904,0.00134266679002282,-0.00337790432220262,0.00188534949468682,0.578338676247862
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24508.Distance (Euclidean) to coast,42742,-0.00096809128391358,0.00127393535582529,-0.00346500458133115,0.00152882201350399,0.447305506137694
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,9446,-0.0241307489110965,0.077782099905201,-0.17658366472529,0.128322166903097,0.756388923702567
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2704.Years since last cervical smear test,17714,0.0730104528419082,0.0547187597226424,-0.0342383162144709,0.180259221898287,0.182127442241959
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2714.Age when periods started (menarche),22570,-0.0453038743240692,0.0474426953997121,-0.138291557307505,0.0476838086593664,0.339629500963794
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2734.Number of live births,23276,0.0105479680078549,0.0456581161808213,-0.0789419397065549,0.100037875722265,0.817300786296574
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2744.Birth weight of first child,18481,0.0517062449860083,0.0504700787923092,-0.0472151094469178,0.150627599418934,0.305615876938585
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2754.Age at first live birth,15745,0.000610110115978853,0.00222082113515292,-0.00374269930892086,0.00496291954087857,0.783532849724146
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2764.Age at last live birth,15698,0.00446845040834323,0.00213932738976059,0.000275368724412471,0.008661532092274,0.0367492482954701
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2794.Age started oral contraceptive pill,17814,5.32742330351817e-05,0.00241041944447118,-0.00467114787812833,0.00477769634419869,0.9823671226034
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2804.Age when last used oral contraceptive pill,16152,0.0029952060747722,0.00211217318607388,-0.00114465336993261,0.00713506551947701,0.156190100202976
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2867.Age started smoking in former smokers,10562,0.0017827665169349,0.0026109546644449,-0.00333470462537711,0.00690023765924691,0.494746610127141
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",16045,0.0575532553682316,0.0662624596151902,-0.0723211654775412,0.187427676214004,0.385098091747378
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,16038,0.0744046668899834,0.0733196526919261,-0.0693018523861919,0.218111186166159,0.31021725634735
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,16066,0.100497570120981,0.0752907748800876,-0.0470723486439912,0.248067488885952,0.181963165510671
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",16014,0.118165673915479,0.0736316841845842,-0.0261524270863056,0.262483774917264,0.108552939081277
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28739.Difficulty with standing for long periods,16084,0.0246728203528586,0.0644995528162729,-0.101746303167036,0.151091943872753,0.702075566638391
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28740.Difficulty with taking care of household responsibilities,16123,-0.0244310473581469,0.0720623915749653,-0.165673334845079,0.116811240128785,0.73459432323592
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28741.Difficulty learning a new task,15990,0.040935498823773,0.0814448467722544,-0.118696400849846,0.200567398497392,0.615241071499556
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28742.Difficulty with joining in community activities,15398,0.0510591916097115,0.0826234797768448,-0.110882828752904,0.213001211972327,0.536601393348427
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28743.Difficulty with being emotionally affected by health problems,16021,0.00393607389397848,0.0705297520956651,-0.134302240213525,0.142174388001482,0.955496028976071
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,16122,-0.00245521018619433,0.0994376596524184,-0.197353023104934,0.192442602732546,0.98030178041317
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,10049,-0.0286232572976831,0.0754482483567325,-0.176501824076879,0.119255309481513,0.704416672345517
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2897.Age stopped smoking,10561,-0.00465778406353676,0.00272472511205895,-0.00999824528317231,0.000682677156098785,0.0873968572943093
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,14345,-0.000842483838448488,0.00478321211232353,-0.0102175795786026,0.00853261190170564,0.860191560393001
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,14345,-0.00122551460616076,0.00519762885888883,-0.0114128671695829,0.00896183795726135,0.81360411892291
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,14345,0.0150785888818882,0.017432810604914,-0.0190897199037432,0.0492468976675197,0.387078212269489
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,14345,0.0195139215505013,0.0182249519939075,-0.0162069843575574,0.0552348274585601,0.284310887957161
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,14345,0.0065969882297818,0.019877885579931,-0.0323636675068829,0.0455576439664465,0.739987933879485
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,14345,0.00561586542120654,0.0167723578565345,-0.0272579559776011,0.0384896868200142,0.737759270744095
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,14345,-0.00461660705826156,0.00755114394908114,-0.0194168491984606,0.0101836350819375,0.540958730555638
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,14345,0.00803122799137283,0.0134713517868508,-0.0183726215108548,0.0344350774936005,0.551070475968701
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29002.Recent lack of interest or pleasure in doing things,14260,-0.0541118447912246,0.0773034509859404,-0.205626608723668,0.0974029191412185,0.483943348472198
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29003.Recent feelings of depression,14249,-0.0535417529111267,0.0752395563512066,-0.201011283359492,0.0939277775372383,0.4767135941898
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",14268,-0.0428517691178953,0.0602963610863449,-0.161032636847131,0.0753290986113407,0.477290575038704
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29005.Recent feelings of tiredness or low energy,14277,-0.061000757857705,0.0612215172909956,-0.180994931748056,0.0589934160326463,0.319075610332948
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29006.Recent poor appetite or overeating,14291,-0.00743850797313368,0.0841288201016437,-0.172330995372355,0.157453979426088,0.92954563940992
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29007.Recent feelings of inadequacy,14230,0.0127781981064988,0.0804823995757346,-0.144967305061941,0.170523701274939,0.873852267438594
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29008.Recent trouble concentrating on things,14288,-0.0527315288716793,0.0810863641337274,-0.211660802573785,0.106197744830426,0.515500432500207
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29009.Recent changes in speed or amount of moving or speaking,14272,-0.0154993210818683,0.14272591827686,-0.295242120904515,0.264243478740778,0.913525255134427
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29010.Recent thoughts of suicide or self-harm,14201,-0.211915070240437,0.161194582530304,-0.527856451999832,0.104026311518958,0.188647535027428
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29038#0.Substances taken for depression_None of options listed,13506,0.0125380670019866,0.00888585446621857,-0.00487820775180184,0.029954341755775,0.15826347856276
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),13506,0.00108654430202674,0.0169572604832244,-0.032149686245093,0.0343227748491465,0.9489110893124
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),13506,-0.00176749085276327,0.00886784888057331,-0.019148474658687,0.0156134929531604,0.842019742031272
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),13506,-0.0167864344890076,0.0263371733214878,-0.0684072941991237,0.0348344252211084,0.523896897090031
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),13506,0.0203981534346118,0.0166004957402108,-0.0121388182162013,0.052935125085425,0.219180336012988
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),13506,0.000166870638699089,0.0179882035948445,-0.035090008407196,0.0354237496845942,0.992598531099583
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),13506,-0.00628277832843072,0.0205639818972539,-0.0465881828470483,0.0340226261901869,0.759972239646603
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),13506,0.0116127491147348,0.0229226516594961,-0.0333156481378775,0.0565411463673471,0.612439690961753
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),13506,-0.00630870117444127,0.0171167257234685,-0.0398574835924395,0.027240081243557,0.7124544970273
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,13506,0.00882837809329098,0.00870505258545873,-0.00823352497420814,0.0258902811607901,0.310521202157646
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,13506,-0.00508326638690558,0.013531824825182,-0.0316056430442623,0.0214391102704512,0.707181020110109
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,13506,0.0391965093230207,0.021303803080241,-0.00255894471425165,0.080951963360293,0.0658073409732938
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,13506,0.0173354210570507,0.02674329105566,-0.0350814294120429,0.0697522715261443,0.516856481735406
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,13506,0.0377392199133782,0.0176780239186289,0.00309029303286554,0.0723881467938908,0.0327945091332454
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,13506,0.0331246970159728,0.0273144433237128,-0.0204116118985043,0.08666100593045,0.225259169699167
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,13506,0.0147244378979567,0.0260821678484695,-0.0363966110850435,0.0658454868809569,0.57239578746007
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,13506,0.0186021274844514,0.0145435781675723,-0.00990328572399026,0.047107540692893,0.20089748046295
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,13506,0.0107612746560465,0.0142921501712865,-0.0172513396796749,0.038773888991768,0.451493090048836
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,13506,-0.0157095953442498,0.0203504358771438,-0.0555964496634515,0.024177258974952,0.440155339761422
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29058.Recent feelings or nervousness or anxiety,14054,0.0211199412004845,0.0700107344801603,-0.11610109838063,0.158340980781599,0.76291025449853
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29059.Recent inability to stop or control worrying,14067,-0.127941524465859,0.0738250861302977,-0.272638693281242,0.016755644349525,0.0831112279870139
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29060.Recent worrying too much about different things,14060,0.0189141808507779,0.0672902035953465,-0.112974618196101,0.150802979897657,0.778650327217717
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29061.Recent trouble relaxing,14065,-0.0253909727994216,0.0716613182158311,-0.165847156502451,0.115065210903607,0.723105083227869
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29062.Recent restlessness,14079,0.132285550715718,0.0998897853066903,-0.0634984284853947,0.328069529916831,0.185419940755691
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29063.Recent easy annoyance or irritability,14038,0.0828531589407421,0.0721816283540355,-0.0586228326331675,0.224329150514652,0.251053067426227
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29064.Recent feelings of foreboding,14035,0.00467672891741882,0.0818826002287994,-0.155813167531028,0.165166625365866,0.954454360729141
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,13506,0.00721961790590698,0.00942269609016496,-0.0112488664308163,0.0256881022426303,0.443573985828936
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,13506,-0.0141955362656326,0.0153327493170869,-0.0442477249271228,0.0158566523958577,0.354550318315621
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',13506,0.0187733246656197,0.0202910419753803,-0.0209971176061256,0.0585437669373651,0.354877082095119
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,13506,0.00324767736016963,0.0216518314489806,-0.0391899122798324,0.0456852670001717,0.880770404903733
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#2.Symptoms of panic attack_Sweating,13506,-0.0196945212402956,0.0142189070679088,-0.0475635790933969,0.00817453661280577,0.166046661469046
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,13506,0.0183438917488304,0.0153368313137411,-0.0117162976261022,0.048404081123763,0.23169107889826
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,13506,0.022120721180182,0.0152848733470938,-0.00783763058012185,0.0520790729404859,0.147855861506179
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,13506,0.00877099536135696,0.0145126264545113,-0.0196737524894852,0.0372157432121991,0.545607870600012
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,13506,-0.0264698046215477,0.0187224501464424,-0.0631658069085747,0.0102261976654794,0.15744363389913
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29076.Felt loved as a child,14012,-0.113708964193771,0.0628158398967278,-0.236828010391358,0.00941008200381528,0.0702868810072224
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29077.Physically abused by family as a child,14035,0.0491798923338319,0.0828789104912872,-0.113262772229091,0.211622556896755,0.552926721003969
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29078.Felt hated by family member as a child,14007,0.0267756457565093,0.085081799076634,-0.139984680433693,0.193535971946712,0.75299053552062
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29079.Sexually molested as a child,13909,0.17144788264352,0.109260809494738,-0.0427033039661664,0.385599069253206,0.116633030481422
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29080.Someone to take to doctor when needed as a child,13987,0.0615072670233826,0.0919241941312664,-0.1186641534739,0.241678687520665,0.503437274010575
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,14009,-0.0404814176426687,0.12079606019232,-0.277241695619615,0.196278860334278,0.737538078749247
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29082.Belittlement by partner or ex-partner as an adult,13931,0.0106070950302982,0.092384415370594,-0.170466359096066,0.191680549156663,0.90859360137889
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29083.Physical violence by partner or ex-partner as an adult,14021,-0.080464924067604,0.105185698582021,-0.286628893288365,0.125699045153157,0.444296522190901
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,13977,-0.11141505486851,0.149988500179558,-0.405392515220445,0.182562405483424,0.457600751949553
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,13976,-0.0145017714093738,0.140304570206804,-0.28949872901471,0.260495186195962,0.91767935839363
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29086.Experienced a violent or sexual assault,14024,-0.113326220974697,0.120996559624716,-0.350479477839141,0.123827035889747,0.348976911405277
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29087.Experienced a life-threatening injury or illness,14028,0.0815173830462517,0.0727365644790009,-0.0610462833325901,0.224081049425094,0.262425918168621
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29088.Experienced a marital separation or divorce,14030,-0.0501195154287408,0.0690944002958973,-0.1855445400087,0.0853055091512179,0.468232654191549
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29089.Experienced the death of a spouse or partner,14048,0.0171647382390969,0.0926230929383501,-0.164376523920069,0.198706000398263,0.852982198057373
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,14028,0.17849335245957,0.0835653020556272,0.0147053604305402,0.342281344488599,0.0326987732978307
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29091.Frequency of drinking alcohol,14030,0.0815416787375318,0.0567561933313454,-0.0297004601919052,0.192783817666969,0.150825300883627
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,12483,0.0280091170144357,0.0668381981928769,-0.102993751443603,0.159011985472474,0.67518057828894
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,12514,-0.0100324434320306,0.0666829822843533,-0.140731088709363,0.120666201845302,0.880412157085516
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29104.Ever used cannabis,14021,0.0700191381741813,0.0808769001920498,-0.0884995862022364,0.228537862550599,0.386642364062804
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29108.Ever thought that life not worth living,13958,0.0564243882173622,0.0708426886232417,-0.0824272814841915,0.195276057918916,0.425769907778104
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29109.Ever contemplated self-harm,13987,0.0772889353639371,0.0964804369454695,-0.111812721049183,0.266390591777057,0.423096634297015
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29111.Ever self-harmed,14014,0.213596929186297,0.152022452982841,-0.0843670786600713,0.511560937032665,0.16003293909727
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,14008,0.0143822372447599,0.102302176146824,-0.186130028003015,0.214894502492535,0.888199159674326
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,14559,0.00632932549793089,0.0204560501807246,-0.0337645328562893,0.0464231838521511,0.757013389735487
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,14559,-0.00379840735544321,0.0161493259598253,-0.0354510862367007,0.0278542715258143,0.814052689409926
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,14559,0.000186744223279768,0.0171564282873587,-0.0334398552199434,0.0338133436665029,0.991315510038098
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,14559,0.00947496543608012,0.0233895951652063,-0.0363686410877242,0.0553185719598845,0.685414978542852
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,13990,0.0983856113103683,0.0641439461325844,-0.027336523109497,0.224107745730234,0.125095259106173
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X29153.Pain or discomfort today,14014,-0.0395170229909635,0.0601114545791608,-0.157335473966119,0.0783014279841917,0.510937205466093
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29154.Anxiety or depression today,14014,-0.0383106624381062,0.0754385742867802,-0.186170268040195,0.109548943163983,0.6115741444611
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29166.Frequency of confiding in someone close,13665,-0.018882713991091,0.0589335292379397,-0.134392431297453,0.0966270033152709,0.74866474224632
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,13970,0.0067204810850583,0.00486259154716201,-0.00281019834737925,0.0162511605174959,0.16696985427691
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,13970,0.0061435367387396,0.00489086570428549,-0.00344256004165996,0.0157296335191392,0.209091824373292
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,13970,-0.0144997735684794,0.00611604613100121,-0.0264872239852418,-0.00251232315171703,0.017764303721892
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,13970,-0.0129177815330814,0.00653799616755293,-0.0257322540214852,-0.000103309044677686,0.0481969483114527
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,13970,-0.0101910258160874,0.0105100015004989,-0.0307906287570652,0.0104085771248904,0.33223764930973
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,13970,-0.00254280248356829,0.00501235333107513,-0.0123670150124755,0.00728141004533896,0.611947366516943
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,13963,-0.00431861353763816,0.00543610807566098,-0.0149733853659337,0.00633615829065736,0.42695799682457
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,13963,0.00475001408585106,0.00796352816948584,-0.0108585011263412,0.0203585292980433,0.550870261241629
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,13963,-0.00914690397617181,0.0123817198646315,-0.0334150749108496,0.015121266958506,0.460075739597362
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,13963,-0.003073756163227,0.0109608177131427,-0.0245569588809867,0.0184094465545328,0.779150798607577
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,13963,-0.0218761192951066,0.0162412494321391,-0.0537089681820992,0.00995672959188595,0.178018845541673
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,13963,0.00262664301362556,0.0077506686032503,-0.012564667448745,0.0178179534759962,0.734695859156873
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29171.Frequency of feeling 'in tune' with people,13724,0.0657824272576772,0.0737030386403348,-0.0786755284773791,0.210240382992733,0.372122738763434
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29172.Freuency of feeling that lacks companionship,13909,0.0362232838260067,0.0665578679956299,-0.0942301374454279,0.166676705097441,0.58628682294344
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29173.Frequency of feeling left out,13831,0.0923715455978622,0.0687106125813866,-0.0423012550616555,0.22704434625738,0.17885526669368
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29174.Frequency of feeling isolated from others,13886,0.0144263798979736,0.0716531183734783,-0.126013732114044,0.154866491909991,0.840438505340206
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29175.Tendency to bounce back quickly after hard times,13995,0.151488909357624,0.0586539696747211,0.0365271287951709,0.266450689920078,0.00981152090652952
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29176.Ability to make it through stressful events,13995,-0.0465770441527218,0.0576254773889482,-0.15952297983506,0.0663688915296166,0.418947929871762
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29177.Quick recovery from stressful events,13995,0.100676412931349,0.059051456427847,-0.015064441667231,0.216417267529929,0.0882366087421202
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29178.Hard to snap back when something bad happens,13995,-0.113189860682926,0.0578067361276848,-0.226491063493189,0.000111342127335851,0.050241205472484
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29179.Comes through difficult times with little trouble,13995,0.0748330626994892,0.0584415171147133,-0.039712310845349,0.189378436244327,0.200398410078488
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29180.Tendency to take a long time to get over setbacks,13995,-0.102094786897102,0.0587831079400156,-0.217309678459533,0.0131201046653281,0.0824436527026889
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29181.General happiness,13916,-0.0131691966942644,0.0600425730798688,-0.130852639930807,0.104514246542278,0.826395447879885
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29182.Belief that own life is meaningful,13753,-0.00494895494825915,0.06037146950404,-0.123277035176178,0.113379125279659,0.934667738828457
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,9610,-0.0932696531781649,0.0714831911780753,-0.233376707887193,0.0468374015308627,0.191999944948586
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2946.Father's age,9368,0.00797880877604534,0.0042895693981034,-0.000428747244237321,0.016386364796328,0.0629099751358358
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2966.Age high blood pressure diagnosed,10733,-0.00333710781753419,0.00309655201349033,-0.00940634976397523,0.00273213412890685,0.281198583533578
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30000.White blood cell (leukocyte) count,41749,-0.0018456856449269,0.00135321398170593,-0.00449798504907053,0.000806613759216726,0.17259776786206
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,41750,-0.00205505909304631,0.00152256767245519,-0.00503929173105848,0.000929173544965854,0.177109119334368
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30020.Haemoglobin concentration,41750,-0.0022803345807882,0.00163481010032214,-0.00548456237741959,0.000923893215843193,0.163064863791836
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30030.Haematocrit percentage,41750,-0.00197925509037226,0.00159765268786078,-0.00511065435857939,0.00115214417783487,0.215407311382833
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30040.Mean corpuscular volume,41750,0.000605533782934186,0.00133599687300292,-0.00201302008815153,0.0032240876540199,0.650374753087555
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30050.Mean corpuscular haemoglobin,41749,0.0004062951302518,0.00134114242874909,-0.00222234403009641,0.00303493429060001,0.761931731195476
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,41749,-0.000187490479895187,0.00131122145892048,-0.00275748453937932,0.00238250357958895,0.886299417572888
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,41750,0.000362963238567598,0.00130569041079724,-0.00219618996659499,0.00292211644373019,0.781024727311693
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30080.Platelet count,41750,-0.000112698589933276,0.00133947167507002,-0.00273806307307052,0.00251266589320396,0.932948230283587
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30090.Platelet crit,41750,0.000457886210269032,0.00136998612758413,-0.00222728659979586,0.00314305902033393,0.73821002950851
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,41750,0.000628844707644131,0.0012818546170587,-0.00188359034179093,0.00314127975707919,0.623730269756874
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30110.Platelet distribution width,41750,0.00070860832622355,0.00130009047085245,-0.00183956899664724,0.00325678564909434,0.58572520815001
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30120.Lymphocyte count,41686,0.000601149903731381,0.00133260996951251,-0.00201076563651313,0.00321306544397589,0.651914662119406
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30130.Monocyte count,41686,-0.00245596786215335,0.0013462945147353,-0.00509470511103454,0.000182769386727852,0.0681225550298134
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30140.Neutrophill count,41686,-0.00267345064085866,0.00134040655452842,-0.00530064748773435,-4.62537939829618e-05,0.0461031473656181
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30150.Eosinophill count,41686,0.00169169587728909,0.00130087528782897,-0.000858019686855684,0.00424141144143386,0.193461186666453
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30160.Basophill count,41686,0.051101034973793,0.0384682504100842,-0.024296735829972,0.126498805777558,0.184054895424166
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30170.Nucleated red blood cell count,41686,-0.0486584040615753,0.182221884121216,-0.405813296939158,0.308496488816007,0.789448675696663
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30180.Lymphocyte percentage,41687,0.0023042208511991,0.00131266836691767,-0.000268609147959531,0.00487705085035774,0.0792031029395128
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30190.Monocyte percentage,41687,-0.00100569646032882,0.00133167095372114,-0.00361577152962225,0.00160437860896461,0.450124897282515
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30200.Neutrophill percentage,41687,-0.00247284918898959,0.00130039045687293,-0.00502161448446053,7.59161064813616e-05,0.0572276716690254
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30210.Eosinophill percentage,41687,0.00213879974940831,0.00128760338313722,-0.000384902881540641,0.00466250238035726,0.0967068492225054
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30220.Basophill percentage,41687,0.0033549606295967,0.00128618083601443,0.000834046191008419,0.00587587506818499,0.00909811600876922
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30230.Nucleated red blood cell percentage,41686,-0.0509420497474476,0.182229591442324,-0.408112048974403,0.306227949479508,0.779825138871736
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30240.Reticulocyte percentage,40987,-0.00135661088136882,0.00138519405742757,-0.00407159123392686,0.00135836947118922,0.327405338577413
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30250.Reticulocyte count,40987,-0.00175775826805187,0.00141665806404829,-0.00453440807358653,0.00101889153748278,0.214694846502495
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30260.Mean reticulocyte volume,40987,4.22942921619237e-05,0.0013176217864412,-0.00254024440926283,0.00262483299358668,0.974393287230434
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30270.Mean sphered cell volume,40987,0.00072050687137972,0.00132863891363332,-0.00188362539934159,0.00332463914210103,0.587622068585575
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30280.Immature reticulocyte fraction,40987,-0.0015889851687599,0.00138434509085722,-0.00430230154684005,0.00112433120932025,0.251047735551972
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30290.High light scatter reticulocyte percentage,40987,-0.00146271126946488,0.00141393955306224,-0.00423403279346687,0.00130861025453712,0.300911622051307
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30300.High light scatter reticulocyte count,40987,-0.00184752652275369,0.00143620949215573,-0.00466249712737891,0.000967444081871534,0.198314013739684
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30500.Microalbumin in urine,13590,-0.00133076283656443,0.00222748461127417,-0.00569663267466181,0.00303510700153294,0.550231280704427
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,41842,-0.00118303438209665,0.00139798006349115,-0.00392307530653929,0.001557006542346,0.397420627672747
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30520.Potassium in urine,41763,0.000662817476943903,0.00130289100814198,-0.00189084889901437,0.00321648385290218,0.610945398483582
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30530.Sodium in urine,41743,-0.000229671851520285,0.00136322960036663,-0.00290160186823889,0.00244225816519832,0.866209419476318
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30600.Albumin,37611,0.00306323470408333,0.00140104158932304,0.000317193189010161,0.00580927621915649,0.0287926337195512
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30610.Alkaline phosphatase,41030,-0.00331416932547283,0.0013463794660367,-0.00595307307890476,-0.000675265572040896,0.0138382127394714
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30620.Alanine aminotransferase,41023,-0.00268469455283382,0.00142217878910654,-0.00547216497948263,0.000102775873814997,0.0590687897064701
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30630.Apolipoprotein A,37362,0.00219702026077893,0.00154034894295669,-0.000822063667416186,0.00521610418897405,0.153786271468978
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30640.Apolipoprotein B,40803,0.00221972401849587,0.00130373122394399,-0.000335589180434346,0.00477503721742609,0.0886518280694589
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30650.Aspartate aminotransferase,40903,-0.00107431232816969,0.00134419603059184,-0.00370893654812969,0.00156031189179031,0.424165784361682
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30660.Direct bilirubin,34788,-0.000565623473995804,0.00146050110650755,-0.0034282056427506,0.00229695869475899,0.698550993487308
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30670.Urea,41018,-0.00192294040358827,0.00138430191242686,-0.0046361721519449,0.000790291344768373,0.164808434182111
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30680.Calcium,37607,0.000231449580260916,0.00136051111149471,-0.00243515219826871,0.00289805135879054,0.864917009988275
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30690.Cholesterol,41042,0.00262646685108458,0.00132279227786723,3.37939864648073e-05,0.00521913971570434,0.0470902407079524
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30700.Creatinine,41028,-1.90136448864476e-05,0.001627832263056,-0.00320956488047621,0.00317153759070332,0.990680700576702
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30710.C-reactive protein,40911,-0.00588505938431851,0.00145229555107332,-0.00873155866442221,-0.00303856010421481,5.08218572498902e-05
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30720.Cystatin C,41044,-0.00280961135235697,0.00154262725147705,-0.00583316076525199,0.000213938060538039,0.0685661480168068
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30730.Gamma glutamyltransferase,41027,-0.00189800190887046,0.00145230198503705,-0.00474451379954308,0.000948509981802166,0.191256706277491
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30740.Glucose,37560,0.00216718621190193,0.00139927554248641,-0.000575393851371437,0.0049097662751753,0.121440252896422
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),40867,0.000289895566303299,0.00141710264284601,-0.00248762561367488,0.00306741674628147,0.83790973358771
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30760.HDL cholesterol,37581,0.00351293233157085,0.00160268588386828,0.000371667999189029,0.00665419666395268,0.028392611338714
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30770.IGF-1,40828,-0.000526890773800293,0.00136648837713132,-0.00320520799297768,0.00215142644537709,0.699809656716198
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30780.LDL direct,40948,0.00218437656364193,0.00130437867369871,-0.000372205636807546,0.00474095876409141,0.0940107398192788
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30790.Lipoprotein A,32822,-0.00110758297293676,0.00145721140630816,-0.00396371732930074,0.00174855138342723,0.447218082797384
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30810.Phosphate,37527,0.00136746660506493,0.00140464446864516,-0.00138563655347959,0.00412056976360944,0.33029514727118
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30830.SHBG,37261,0.00125971809539681,0.00161608820046876,-0.00190781477752196,0.00442725096831557,0.43569844551907
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30840.Total bilirubin,40879,-0.000299776715384995,0.00138064404858022,-0.00300583905060223,0.00240628561983224,0.828109545246348
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30850.Testosterone,37033,0.00172406825820027,0.0022604818463216,-0.00270647616059007,0.00615461267699062,0.445647519166011
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30860.Total protein,37579,-0.000892631894817459,0.00138334434277575,-0.00360398680665793,0.00181872301702301,0.518755566705163
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30870.Triglycerides,41012,-0.00179394497096377,0.00141301468350722,-0.00456345375063792,0.00097556380871038,0.20423901460571
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30880.Urate,40988,-0.000732100266965204,0.00164074203998905,-0.00394795466534374,0.00248375413141334,0.655454626313133
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30890.Vitamin D,39175,-0.000409869024384504,0.00147161554337468,-0.00329423548939887,0.00247449744062986,0.780617468360559
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X3137.Number of measurements made,38999,-0.0163205069548884,0.0436786384233102,-0.101930638264576,0.0692896243547996,0.708667038705219
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X3143.Ankle spacing width,24266,0.00459092417394594,0.00233439992322437,1.55003244261803e-05,0.00916634802346569,0.0492361180338626
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",24265,-0.00108981195445261,0.00179096016023652,-0.00460009386851618,0.00242046995961097,0.542856904653502
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X3146.Speed of sound through heel,24266,-0.00119174983872787,0.00173478971946085,-0.00459193768887113,0.00220843801141539,0.492107713541667
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",24266,-0.00113571162086383,0.00175175681328954,-0.00456915497491133,0.00229773173318368,0.516779471812771
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X3148.Heel bone mineral density (BMD),24246,-0.00106196933318147,0.00175568577174981,-0.0045031134458111,0.00237917477944815,0.545268134874369
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X3526.Mother's age at death,25653,-0.0002807396,0.001690553,-0.003594224,0.003032745,0.8681081
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X3581.Age at menopause (last menstrual period),13336,-0.00141661317738076,0.00233605723678861,-0.00599528536148643,0.00316205900672491,0.544251523731826
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",8469,0.00247560026179555,0.0030255357123388,-0.00345444973438851,0.0084056502579796,0.413245874674203
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4100.Ankle spacing width (left),14021,0.00244217001548936,0.00310333319621879,-0.00364036304909947,0.0085247030800782,0.431324081612332
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4101.Heel broadband ultrasound attenuation (left),14019,0.000641364695677432,0.00237898439503619,-0.0040214447185935,0.00530417410994836,0.787475043791894
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4103.Speed of sound through heel (left),14021,0.00214247768254592,0.00230788472453235,-0.00238097637753749,0.00666593174262933,0.353252625485427
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",14021,0.00169595595398921,0.00232972517873386,-0.00287030539632916,0.00626221730430757,0.466647820235627
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4105.Heel bone mineral density (BMD) (left),14012,0.00143762613982945,0.00233028870997946,-0.00312973973173029,0.0060049920113892,0.537290613173669
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",14021,0.00169924727481856,0.00232972881610517,-0.00286702120474757,0.00626551575438468,0.465784155582051
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4119.Ankle spacing width (right),14007,0.00504415075990569,0.00306414738313423,-0.000961578111037395,0.0110498796308488,0.0997483151942436
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4120.Heel broadband ultrasound attenuation (right),14006,-0.00147621206522875,0.00239025040238093,-0.00616110285389537,0.00320867872343788,0.536850911422857
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4122.Speed of sound through heel (right),14007,-0.000377894041896969,0.00230885349717056,-0.00490324689635127,0.00414745881255733,0.869991938808605
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",14007,-0.000766622509955488,0.00233466125202645,-0.00534255856392733,0.00380931354401636,0.742640141151003
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4124.Heel bone mineral density (BMD) (right),13996,-0.000678641391726064,0.00233571565959671,-0.00525664408453562,0.00389936130108349,0.771400074061267
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",14007,-0.000766674531296112,0.00233466556874418,-0.0053426190460347,0.00380926998344247,0.742623755087945
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4194.Pulse rate,14579,0.000165817975093164,0.00222692320916781,-0.00419895151487574,0.00453058746506207,0.940644935894894
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4195.Pulse wave reflection index,14579,-0.00152017736200394,0.00226843750783265,-0.00596631487735593,0.00292596015334805,0.502777303732916
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4196.Pulse wave peak to peak time,14570,0.000374060292181251,0.00225884681761775,-0.00405327947034953,0.00480140005471203,0.86847569883474
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4198.Position of the pulse wave peak,14579,-0.00236856151606244,0.00228035359355235,-0.00683805455942505,0.00210093152730018,0.298970043581757
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4199.Position of pulse wave notch,14579,-0.00213859090208425,0.00221177093789997,-0.0064736619403682,0.0021964801361997,0.333603394382839
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4200.Position of the shoulder on the pulse waveform,14579,-0.0027766679086014,0.00229178414583367,-0.00726856483443539,0.00171522901723259,0.225694843046873
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4269.Number of triplets attempted (left),14293,-0.247276375711748,0.175077998242319,-0.590429252266693,0.0958765008431977,0.157860400222206
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4270.Volume level set by participant (left),14144,-0.00531319042243078,0.0594533293450284,-0.121841715938686,0.111215335093825,0.92879118486282
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4276.Number of triplets attempted (right),14297,0.144025020488893,0.1906892350602,-0.229725880229099,0.517775921206884,0.450089513786989
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4277.Volume level set by participant (right),14139,-0.0131693325456078,0.0587615560612884,-0.128341982425733,0.102003317334517,0.822671243090086
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X4288.Time to answer,14604,-0.00528715979907839,0.00259164252493593,-0.0103667791479528,-0.000207540450203969,0.0413602624727658
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X4290.Duration screen displayed,14604,-0.00436908501723938,0.00232385723722817,-0.00892384520220659,0.000185675167727843,0.0601142971491974
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X46.Hand grip strength (left),42939,0.00698311188506895,0.00184011616531236,0.00337648420105672,0.0105897395690812,0.000147887887079258
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X47.Hand grip strength (right),42942,0.00401433033096725,0.00182992907579597,0.000427669342407143,0.00760099131952736,0.0282617392591627
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X48.Waist circumference,43066,-0.002413414,0.002838543,-0.007976958,0.00315013,0.395202
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X4803.Tinnitus,14323,-0.0449138561991375,0.0704741354390469,-0.183043161659669,0.0932154492613944,0.523933276379425
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X4825.Noisy workplace,14523,0.0860792253214679,0.0782423114648714,-0.06727570514968,0.239434155792616,0.271279757824509
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X4836.Loud music exposure frequency,14427,-0.108087869384762,0.101993888566077,-0.307995890974273,0.0918201522047494,0.28927679766945
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X49.Hip circumference,43058,-0.00123528787232048,0.00227228259105886,-0.00568896175079584,0.00321838600615488,0.586696840436222
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X50.Standing height,43021,0.00267242979058431,0.00180219821896683,-0.000859878718590672,0.00620473829975929,0.138115673800468
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X5057.Number of older siblings,12849,-0.0382174808385962,0.062958763924796,-0.161616658131196,0.085181696454004,0.54384572203412
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X51.Seated height,42834,0.00142853372011884,0.00167829714709112,-0.00186092868817975,0.00471799612841743,0.39467388113219
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5181.Ever had eye surgery,9880,-0.220202519312576,0.146599243766464,-0.507537037094845,0.0671319984696924,0.133110701677291
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5186.Duration visual-acuity screen displayed (right),9856,0.00201629000020663,0.00271091609352075,-0.00329710554309403,0.0073296855435073,0.457035187301911
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5188.Duration visual-acuity screen displayed (left),9854,0.00372784587137598,0.00273873762267102,-0.00164007986905921,0.00909577161181118,0.173495942848969
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5190.Duration at which refractometer first shown (right),9744,0.00354913925010609,0.00275307773203747,-0.00184689310468736,0.00894517160489954,0.197375441875446
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5193.Duration at which refractometer first shown (left),9741,0.00192783678011875,0.00277693365304948,-0.00351495317985823,0.00737062674009573,0.487553177236352
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5199.logMAR, initial (right)",9817,-8.27277161981023e-05,0.0732277352349268,-0.143609088776655,0.143443633344258,0.999098627456385
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5200.Final number of letters displayed (right),9817,0.625650090988166,0.520847751783986,-0.395211502508446,1.64651168448478,0.229696869899791
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5201.logMAR, final (right)",9722,0.000711059516704918,0.00276304306497099,-0.00470450489063823,0.00612662392404806,0.796916738012839
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5202.Number of rounds to result (right),9817,-0.0166201420072752,0.0692834454502537,-0.152415695089772,0.119175411075222,0.810423505570534
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5206.logMAR, initial (left)",9812,-0.0520090227322967,0.0743579035895251,-0.197750513767766,0.0937324683031725,0.484292605367585
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5207.Final number of letters displayed (left),9812,-0.26395818262676,0.422404627816358,-1.09187125314682,0.563954887893301,0.532055084054618
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5208.logMAR, final (left)",9720,-0.00495929244790696,0.00276036544100369,-0.0103696087122742,0.000451023816460273,0.0724290809242784
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5209.Number of rounds to result (left),9806,0.118284904766281,0.0699461409692136,-0.0188095315333777,0.255379341065939,0.0908523330505673
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",9399,0.000304036181211654,0.00270044944948157,-0.00498884473977222,0.00559691710219553,0.910360200593384
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",9399,-0.0020224163596301,0.00268281991470501,-0.00728074339245191,0.00323591067319172,0.450964349529151
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5256.Corneal hysteresis (right),9399,-0.00311708129420808,0.00271698972003112,-0.00844238114546908,0.00220821855705292,0.251305301405123
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5257.Corneal resistance factor (right),9399,-0.00340269926780247,0.00269659862393166,-0.00868803257070853,0.00188263403510359,0.207034620285807
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",9369,-0.00205045006908408,0.00271937727857952,-0.00738042953509993,0.00327952939693177,0.450859455258817
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",9369,-0.005300729735402,0.00269653072268732,-0.0105859299518691,-1.55295189348485e-05,0.0493559795500668
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5264.Corneal hysteresis (left),9369,-0.00415226472935757,0.00274135051636138,-0.00952531174142587,0.00122078228271072,0.129887622164939
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5265.Corneal resistance factor (left),9369,-0.00638801225648108,0.00271781247825054,-0.0117149247138521,-0.00106109979911002,0.018772678683246
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,9753,0.719841186617594,0.276688506851072,0.177531713189493,1.2621506600457,0.00929222294220746
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",42946,-0.00143817932959219,0.00730381278517885,-0.0157536523885427,0.0128772937293584,0.843900447925755
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",42946,-0.00750677848162223,0.00789738415274682,-0.022985651421006,0.00797209445776153,0.341843357706871
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",42946,0.00842066814557479,0.00760713602104804,-0.00648931845567937,0.023330654746829,0.268324651522775
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",42946,-0.00245661887766291,0.00325574830026476,-0.00883788554618184,0.00392464779085602,0.450524279285214
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",42946,0.000902188700014987,0.00299715317839386,-0.00497223152963698,0.00677660892966696,0.763404352273478
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",19386,-0.00403087502948709,0.00378556989061121,-0.0114505920150851,0.00338884195611087,0.2869796915503
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",19386,-0.0157725067762145,0.010188512453749,-0.0357419911855625,0.00419697763313343,0.121622339340507
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",19386,-0.000181137091375698,0.00734377595003844,-0.014574937953451,0.0142126637706996,0.980322116214109
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",19386,4.3671007860898e-05,0.00448655491372306,-0.0087499766230363,0.0088373186387581,0.992233813319228
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,43069,7.05288131306566e-05,0.00500789736339898,-0.00974495001913135,0.00988600764539267,0.988763415062996
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,43069,0.00209334613634198,0.00638069738322931,-0.0104128207347875,0.0145995130074714,0.742856688429541
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),43069,0.00428489722632433,0.00495239053291096,-0.00542178821818115,0.0139915826708298,0.386923991171783
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',43069,-0.00445857005774249,0.008083307118615,-0.0203018520102279,0.0113847118947429,0.581240741230619
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),43069,-0.0152992630083686,0.0200456917104653,-0.0545888187608806,0.0239902927441434,0.445336676929947
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),43069,-0.00132536894804433,0.0137560608249515,-0.0282872481649493,0.0256365102688606,0.923244638339151
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,43069,0.039661371191332,0.0216063903727907,-0.00268715393933779,0.0820098963220017,0.066419064988671
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,42945,-0.00346005841905513,0.00416792100497725,-0.0116291835888105,0.00470906675070029,0.406450621988773
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,42945,0.00395689442052248,0.00707872121657863,-0.00991739916397162,0.0178311880050166,0.57617531255089
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,42945,0.00376615422387126,0.00373217720737669,-0.00354891310258706,0.0110812215503296,0.312930540289043
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,42945,0.0134469709991284,0.00620790659292389,0.00127947407699753,0.0256144679212592,0.0303087297375223
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,42945,-0.00530925179572787,0.00616377586020953,-0.0173902524817385,0.00677174889028281,0.389042660954443
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,42945,-0.00201492350866494,0.00348696714200351,-0.00884937910699182,0.00481953208966193,0.563372386151811
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,13310,0.00377065131370259,0.008258682316353,-0.0124163660263493,0.0199576686537545,0.647988933755824
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,13310,-0.00242696571542559,0.0071244966163777,-0.0163909790835259,0.0115370476526747,0.733371837718475
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,13310,0.0137640720822763,0.00977747300202178,-0.00539977500168638,0.032927919166239,0.159233504030077
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,13310,-0.00921940859001284,0.00778550387097947,-0.0244789961771326,0.00604017899710691,0.236364479525804
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,42895,-0.0127435190373432,0.0105017166759269,-0.0333268837221599,0.00783984564747357,0.224956828504134
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#2.Fractured bone site(s)_Leg,42895,0.0426397475194864,0.0159923459571629,0.0112947494434472,0.0739847455955256,0.00767291803939204
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#3.Fractured bone site(s)_Hip,42895,-0.0116170221218358,0.0276042449613166,-0.0657213422460163,0.0424872980023447,0.673872662794319
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#4.Fractured bone site(s)_Spine,42895,0.0303014378629947,0.0265773452665778,-0.0217901588594979,0.0823930345854872,0.254241503531729
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,42895,-0.00121500348689619,0.0092226836859661,-0.0192914635113897,0.0168614565375974,0.895189951672221
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#6.Fractured bone site(s)_Arm,42895,-0.0106861206790497,0.012259481381903,-0.0347147041875795,0.0133424628294801,0.383397827152911
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,42895,0.00255969311596937,0.00564770923084362,-0.00850981697648413,0.0136292032084229,0.650387737957593
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",13951,0.00221031487818811,0.00913278914114389,-0.0156899518384539,0.0201105815948301,0.808768460268581
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",13951,-0.00250580322452136,0.00970805743363768,-0.0215335957944512,0.0165219893454085,0.796321332262095
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",13951,-0.0310024407986159,0.0133509480153734,-0.0571702989087477,-0.00483458268848403,0.0202410621847785
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",13951,0.000169887866044349,0.00469171138286815,-0.00902586644437722,0.00936564217646592,0.971115261541366
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",19496,-0.00757025686481641,0.00423599918372021,-0.015872815264908,0.0007323015352752,0.0739329500483657
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",19496,-0.00033419781066809,0.00412770343127839,-0.00842449653597374,0.00775610091463756,0.935470945798796
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",19496,0.00233407621406649,0.00378057430338774,-0.00507584942057349,0.00974400184870646,0.536986921932823
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",19497,0.00494820469810819,0.00890960318769481,-0.0125146175497736,0.02241102694599,0.578641968948035
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",19497,0.00815711121710942,0.00533196949507503,-0.00229354899323763,0.0186077714274565,0.126070204524768
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",19497,-0.00079216248469497,0.00727986775115189,-0.0150607032769527,0.0134763783075627,0.913349946348608
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,42945,0.00244092285516834,0.00872010239834084,-0.0146504778455797,0.0195323235559164,0.779540953383883
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,42945,0.00698271569653704,0.00610234847295163,-0.00497788731044815,0.0189433187035222,0.25251932350706
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,42945,-0.00860255314243672,0.0174823837746056,-0.0428680253406638,0.0256629190557903,0.622672514515534
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,42945,0.00479310195952996,0.00627394079232369,-0.00750382199342447,0.0170900259124844,0.444889374985684
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,42945,0.0072595379049444,0.00711134940648301,-0.0066787069317623,0.0211977827416511,0.307336803312456
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),42945,-0.0184090528948499,0.00819245190012686,-0.0344662586190985,-0.00235184717060125,0.0246403000207429
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,42945,-0.00430339826176788,0.00271560104716751,-0.00962597631421621,0.00101917979068045,0.113043109373461
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,8381,-0.00726255754031359,0.00786658789080656,-0.0226810698062945,0.00815595472566727,0.355921424321262
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,8381,-0.0121776771064691,0.00992207765580904,-0.0316249493118548,0.00726959509891664,0.21973260209966
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,8381,0.00434491322844234,0.00703591587564662,-0.00944548188782504,0.0181353083447097,0.536899747191674
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,8381,0.00268296364722075,0.00630094493920391,-0.00966688843361892,0.0150328157280604,0.670262076685381
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,43133,-0.00232546904890142,0.00317305301543817,-0.00854465295916025,0.0038937148613574,0.463635230562105
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,43133,-0.00102016318839302,0.00915171323625034,-0.0189575211314437,0.0169171947546576,0.911242291309467
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,43133,-0.00357732150510078,0.00297275616822076,-0.00940392359481348,0.00224928058461192,0.228840310008675
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,43133,0.00309327063254564,0.00287804692879022,-0.00254770134788319,0.00873424261297447,0.282478728872363
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,43133,0.00703692081735013,0.00446296955780959,-0.00171049951595666,0.0157843411506569,0.114863823041442
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,43133,-0.00224999212090743,0.00395928054395259,-0.0100101819870545,0.00551019774523965,0.569845729091704
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,43133,-0.00019212680196907,0.00309213623241127,-0.00625271381749515,0.00586846021355701,0.950456406803504
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,43133,-0.00638776693888613,0.0090174189167421,-0.0240619080157006,0.0112863741379284,0.478712606403564
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,29865,3.75673361042771e-05,0.00315341871389749,-0.0061431333431348,0.00621826801534335,0.990494938942377
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,29865,-9.35784174766345e-05,0.0032936730951041,-0.00654917768388067,0.0063620208489274,0.977334087836688
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,29865,-0.00274180731577787,0.00370686407246385,-0.010007260897807,0.00452364626625128,0.45951406769264
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,29866,-0.000217104622165377,0.00505048030927187,-0.0101160460283382,0.00968183678400748,0.965712243445865
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,29866,-0.00551633919996872,0.00333471098359309,-0.0120523727278112,0.00101969432787373,0.09809372410739
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,42749,-0.00465568408105905,0.00320133983656679,-0.01093031016073,0.00161894199861185,0.145872610550044
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,42749,0.00361047050025575,0.00255473973068578,-0.00139681937188838,0.00861776037239989,0.157591287761117
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,42749,0.00487699360780977,0.00283171151084115,-0.000673160953438895,0.0104271481690584,0.0850264595550929
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,42749,0.00283968572132875,0.00514689782085518,-0.0072482340075474,0.0129276054502049,0.581137863703902
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),42778,-0.0016306334681493,0.00282119129415697,-0.00716016840469696,0.00389890146839836,0.56327077621278
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,42778,0.00847677787874768,0.00442233647195924,-0.000191001606292422,0.0171445573637878,0.0552687563779262
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),42945,-0.000654748052655655,0.0027753672890361,-0.00609446793916642,0.00478497183385511,0.813500514680491
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,42945,0.00784365168258885,0.00328959289504041,0.00139604960830965,0.014291253756868,0.0171120704234975
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,42945,-0.000836942531948979,0.00493995966032241,-0.0105192634661809,0.00884537840228295,0.865464772245061
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,42945,-0.00640255172506803,0.00636151020841264,-0.0188711117335568,0.00606600828342074,0.314204085633946
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,42945,-0.0042117623595811,0.00684110304092016,-0.0176203243197846,0.00919679960062241,0.538125210877135
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,42945,-0.00871300080542531,0.00816158973814125,-0.0247097166921822,0.00728371508133154,0.285724260383269
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",24266,-0.00113589788091082,0.00175175863625911,-0.00456934480797867,0.00229754904615704,0.516711155321558
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X864.Number of days or week walked 10+ minutes,42213,-0.0319479745929587,0.034232309041155,-0.0990433003136224,0.0351473511277051,0.350686109011112
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X874.Duration of walks,36559,-0.0031115184947447,0.00136794474050218,-0.00579269018612897,-0.000430346803360424,0.0229360824750814
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,40774,-0.0139284126893604,0.0332529404400301,-0.0791041759518194,0.0512473505730986,0.675318767773493
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X894.Duration of moderate activity,31564,-0.00733442028763473,0.0402181563157704,-0.0861620066665447,0.0714931660912752,0.855296756326173
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X90087.No-wear time bias adjusted average acceleration,8834,0.00530325424239016,0.00298826508716536,-0.000553745328453939,0.0111602538132343,0.0759830149064826
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,40726,0.0227961386327124,0.0341950504195448,-0.0442261601895953,0.0898184374550202,0.504999347283412
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X914.Duration of vigorous activity,22778,0.000911672074667669,0.0017408770700886,-0.00250044698270598,0.00432379113204132,0.600502402155052
